Embed Size (px)
Citation preview
EVALUATIONORIGINAL
U-A 2011 Urine Chemistry-Genl
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:2/11/20111/4/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23921478 Kit ID:
Claudia Velasquez MT
Next Mailing Date:7/11/2011
COPIED TO: LAP CAP
IMPORTANT NOTES: NOTE:
Due to variability of Urine Albumin results, participants are graded by peer group only. If a peer group had less than 10 participants, theresults will receive code 20 'No appropriate target.'
LEGEND: Exception Reason Codes appearing in this evaluation:[20] = No appropriate target/response cannot be graded.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 5
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-01 36.40 33.707 1.983 84 +1.4 23.25 44.16 AcceptableU-02 16.40 15.678 0.566 93 +1.3 10.81 20.54 AcceptableU-03 34.50 34.865 1.541 86 -0.2 24.05 45.68 Acceptable
TestUnit of Measure
Peer Group
Calcium, urinemg/dL
ABBOTT ARCH C/AEROSETARSENAZO III DYE
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-A 2011U-B 2010U-A 2010
x: Result is outside the acceptable limitsU-01 207.0 209.71 3.37 55 -0.8 167.7 251.7 AcceptableU-02 81.0 81.84 1.45 56 -0.6 65.4 98.3 AcceptableU-03 249.0 255.29 4.78 56 -1.3 204.2 306.4 Acceptable
Glucose, urinemg/dL
ABBOTT ARCH C/AEROSETHEXOKINASE, UV
U-A 2011U-B 2010U-A 2010
U-01 1U-02 1U-03 1
U-01 14.6 15.66 0.70 1178 -1.5 11.7 19.6 AcceptableU-02 9.6 10.71 0.54 1181 -2.1 8.0 13.4 AcceptableU-03 9.4 10.23 0.68 1178 -1.2 7.6 12.8 Acceptable
Magnesium, urinemg/dL
ABBOTT ARCH C/AEROSETCOLOR-DYE-XYLIDYL MAGO
All Methods/All Instruments
U-A 2011U-B 2010U-A 2010
U-01 134.32 137.577 3.440 100 -0.9 114.18 160.97 AcceptableU-02 50.29 50.268 1.155 98 0.0 41.72 58.82 AcceptableU-03 29.89 29.062 1.116 97 +0.7 24.12 34.01 Acceptable
Creatininemg/dL
ABBOTT ARCH C/AEROSETKINETIC ALK. PICRATE
U-A 2011U-B 2010U-A 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239214781/4/20112/11/2011
U-A 2011 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-01 148 16 [20]U-02 158 16 [20]U-03 128 16 [20]
TestUnit of Measure
Peer Group
Osmolality, urinemmol/kg
OTHER
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-01 83.50 85.315 2.046 62 -0.9 65.69 104.94 AcceptableU-02 110.60 112.754 2.947 62 -0.7 86.82 138.69 AcceptableU-03 38.80 39.811 0.990 62 -1.0 30.65 48.97 Acceptable
Phosphorus, urinemg/dL
ABBOTT ARCH C/AEROSETPHOSPHOMOLYBDATE UV
U-A 2011U-B 2010U-A 2010
U-01 90 95.3 1.2 116 -4.3 67 123 AcceptableU-02 8 8.0 0.0 118 0.0 5 11 AcceptableU-03 46 47.9 0.7 119 -2.7 34 62 Acceptable
Potassium, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
U-A 2011U-B 2010U-A 2010
U-04 25 25.9 0.8 107 -1.2 19 33 AcceptableU-05 23 24.2 0.7 105 -1.8 17 31 AcceptableU-06 51 53.2 0.5 104 -4.1 39 68 Acceptable
Chloride, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
U-A 2011U-B 2010U-A 2010
U-04 11.4 10.79 0.55 63 +1.1 7.5 14.1 AcceptableU-05 1.2 1.32 0.08 63 -1.5 0.9 1.8 AcceptableU-06 3.0 2.94 0.20 63 +0.3 2.0 3.9 Acceptable
Urine albuminmg/dL
BECKMAN IMMAGENEPHELOMETRY
U-A 2011
U-A 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239214781/4/20112/11/2011
U-A 2011 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-04 94.64 96.125 2.084 100 -0.7 79.78 112.47 AcceptableU-05 58.74 60.760 1.550 100 -1.3 50.43 71.09 AcceptableU-06 135.58 141.746 2.851 99 -2.2 117.64 165.85 Acceptable
TestUnit of Measure
Peer Group
Creatinine, urinemg/dL
ABBOTT ARCH C/AEROSETKINETIC ALK. PICRATE
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-A 2011U-B 2010U-A 2010
U-04 1U-05 1U-06 1
U-04 605.0 606.80 36.36 1814 0.0 479.3 734.3 AcceptableU-05 479.0 473.28 29.70 1820 +0.2 373.8 572.7 AcceptableU-06 807.0 802.33 48.66 1818 +0.1 633.8 970.9 Acceptable
Urea nitrogen, urinemg/dL
ABBOTT ARCH C/AEROSETOTHER
All Methods/All Instruments
U-A 2011U-B 2010
U-04 24.50 24.568 0.763 77 -0.1 18.67 30.47 AcceptableU-05 13.10 13.220 0.645 75 -0.2 10.04 16.40 AcceptableU-06 24.00 24.084 0.777 77 -0.1 18.30 29.87 Acceptable
Uric Acid, urinemg/dL
ABBOTT ARCH C/AEROSETURICASE
U-A 2011U-B 2010U-A 2010
U-04 142 139.2 2.6 84 +1.1 131 148 AcceptableU-05 48 46.8 1.1 83 +1.1 43 50 AcceptableU-06 204 197.9 3.8 84 +1.6 186 210 Acceptable
Amylase, urineU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
U-A 2011U-B 2010U-A 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239214781/4/20112/11/2011
U-A 2011 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-04 124.50 126.737 2.393 99 -0.9 70.97 182.51 AcceptableU-05 16.70 16.426 0.712 101 +0.4 9.19 23.66 AcceptableU-06 149.20 150.089 2.750 101 -0.3 84.04 216.13 Acceptable
TestUnit of Measure
Peer Group
Protein, Totalmg/dL
ABBOTT ARCH C/AEROSETBENZETHONIUM CHLORIDE
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-A 2011U-B 2010U-A 2010
U-04 22 21.3 1.1 106 +0.7 15 27 AcceptableU-05 39 41.9 1.0 117 -2.9 30 53 AcceptableU-06 55 57.9 1.2 118 -2.5 42 74 Acceptable
Sodium, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
U-A 2011U-B 2010U-A 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239214781/4/20112/11/2011
U-A 2011 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Blood Gas / Electrolytes (BGAS435) - Performance Report
Laboratory Results Summary
A ACC 7.036 - 7.1170.0144 0.2
B ACC 7.566 - 7.6470.0114 0.2
C ACC 6.953 - 7.0340.0148 0.2
D ACC 7.308 - 7.3890.0083 0.1
E ACC 7.607 - 7.6880.0092 0.1
A ACC 62.8 - 73.82.71 4.0
B ACC 18.6 - 28.70.65 2.8
C ACC 66.4 - 78.01.85 2.6
D ACC 39.2 - 49.31.05 2.4
E ACC 16.5 - 26.60.69 3.2
CO1033AI PageLaboratorio Medico Las Americas
CAP LAP Number 7181660
Instrument Nickname: GemSubscription ID 32219 Cycle: 01 - 2011
Results Deadline 2011/Feb/15
Analyte Sample Problem Code
SDICOMPARATIVE GROUP DATA
CV(%)
» pH
ID:IL GEM Premier 3000 7.07
ID:IL GEM Premier 3000 7.62
ID:IL GEM Premier 3000 6.99
ID:IL GEM Premier 3000 7.35
ID:IL GEM Premier 3000 7.63
Analyte Score: 100.00%
» pCO2 mm Hg
ID:IL GEM Premier 3000 71
ID:IL GEM Premier 3000 24
ID:IL GEM Premier 3000 72
ID:IL GEM Premier 3000 45
ID:IL GEM Premier 3000 23
Analyte Score: 100.00%
Grade: ACC - Acceptable; UNACC - Unacceptable; *ACC or *UNACC: Ungradable result due to either lack of peer group consensus or insufficient number of participants. As required by CLIA/CAP, you must verify the accuracy of these ungradable results.» This result is designated for regulatory purposes.Peer Group(PG) Codes: AR-all results; AU-all results in specific unit; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument modelProblem Codes: 1(Failure to participate); 2(Failure - Excl Requested); 11(Below Linear/Detection Limit); 22(Above Linear/Detection Limit); 33(Analyzer Out of Service); 66(Specimen Not Appropriate); 88(Testing Suspended During Test Event);
DigitalPT Support from AccuTest Member_DigitalPT International EQA [email protected] | tel 604.222.3900 | fax 604.222.3901 | www.digitalpt.comPO Box 999 Westford, MA, 01886, USA
80 7.0763-0.44
80 7.60691.15
78 6.9935-0.23
80 7.34840.19
80 7.6479-1.94
80 68.310.99
77 23.610.60
71 72.18-0.10
78 44.210.76
79 21.572.07
1 of 3 2011/Feb/25Print Date
Instrument Model: IL GEM Premier 3000
YOUR LAB'S DATAResult Grade Peer Group Code:Description Acceptable Results
Laboratory
Test event
1 / 4
Statistical Count
Contact Name Lucia Ochoa Fax 011-574-3400510Email [email protected]
Mean SD
Blood Gas / Electrolytes (BGAS435) - Performance Report
Laboratory Results Summary
A ACC 30.0 - 43.02.15 5.9
B ACC 64.2 - 78.92.43 3.4
C ACC 104.3 - 128.44.00 3.4
D ACC 170.6 - 203.55.47 2.9
E ACC 117.7 - 140.53.78 2.9
A ACC 1.89 - 2.050.026 1.3
B ACC 0.75 - 0.870.018 2.2
C ACC 2.04 - 2.400.057 2.6
D ACC 1.42 - 1.550.020 1.3
E ACC 0.52 - 0.630.016 2.8
CO1033AI PageLaboratorio Medico Las Americas
CAP LAP Number 7181660
Instrument Nickname: GemSubscription ID 32219 Cycle: 01 - 2011
Results Deadline 2011/Feb/15
Analyte Sample Problem Code
SDICOMPARATIVE GROUP DATA
CV(%)
» pO2 mm Hg
ID:IL GEM Premier 3000 36
ID:IL GEM Premier 3000 73
ID:IL GEM Premier 3000 126
ID:IL GEM Premier 3000 190
ID:IL GEM Premier 3000 131
Analyte Score: 100.00%
» Calcium - Ionized mmol/L
ID:IL GEM Premier 3000 1.94
ID:IL GEM Premier 3000 0.80
ID:IL GEM Premier 3000 2.15
ID:IL GEM Premier 3000 1.51
ID:IL GEM Premier 3000 0.60
Analyte Score: 100.00%
Grade: ACC - Acceptable; UNACC - Unacceptable; *ACC or *UNACC: Ungradable result due to either lack of peer group consensus or insufficient number of participants. As required by CLIA/CAP, you must verify the accuracy of these ungradable results.» This result is designated for regulatory purposes.Peer Group(PG) Codes: AR-all results; AU-all results in specific unit; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument modelProblem Codes: 1(Failure to participate); 2(Failure - Excl Requested); 11(Below Linear/Detection Limit); 22(Above Linear/Detection Limit); 33(Analyzer Out of Service); 66(Specimen Not Appropriate); 88(Testing Suspended During Test Event);
DigitalPT Support from AccuTest Member_DigitalPT International EQA [email protected] | tel 604.222.3900 | fax 604.222.3901 | www.digitalpt.comPO Box 999 Westford, MA, 01886, USA
71 36.54-0.25
75 71.510.61
75 116.312.42
75 187.070.54
75 129.120.50
28 1.970-1.13
30 0.810-0.57
30 2.221-1.23
29 1.4881.11
30 0.5731.66
1 of 3 2011/Feb/25Print Date
Instrument Model: IL GEM Premier 3000
YOUR LAB'S DATAResult Grade Peer Group Code:Description Acceptable Results
Laboratory
Test event
2 / 4
Statistical Count
Mean SD
Blood Gas / Electrolytes (BGAS435) - Performance Report
Laboratory Results Summary
A ACC 5.9 - 7.40.27 4.0
B ACC 17.0 - 20.90.28 1.5
C UNACC 19.2 - 23.50.62 2.9
D ACC 9.4 - 11.60.34 3.2
E ACC 2.2 - 2.90.12 4.7
A ACC 2.0 - 3.10.11 4.3
B ACC 7.9 - 11.90.31 3.1
C ACC 7.6 - 11.60.41 4.2
D ACC 3.7 - 5.60.15 3.3
E ACC 1.4 - 2.20.09 5.1
CO1033AI PageLaboratorio Medico Las Americas
CAP LAP Number 7181660
Instrument Nickname: GemSubscription ID 32219 Cycle: 01 - 2011
Results Deadline 2011/Feb/15
Analyte Sample Problem Code
SDICOMPARATIVE GROUP DATA
CV(%)
» Glucose mmol/L
ID:IL GEM Premier 3000 6.8
ID:IL GEM Premier 3000 18.9
ID:IL GEM Premier 3000 19.0
ID:IL GEM Premier 3000 10.1
ID:IL GEM Premier 3000 2.6
Analyte Score: 80.00%
» Lactate mmol/L
ID:IL GEM Premier 3000 2.5
ID:IL GEM Premier 3000 9.8
ID:IL GEM Premier 3000 9.1
ID:IL GEM Premier 3000 4.5
ID:IL GEM Premier 3000 1.7
Analyte Score: 100.00%
Grade: ACC - Acceptable; UNACC - Unacceptable; *ACC or *UNACC: Ungradable result due to either lack of peer group consensus or insufficient number of participants. As required by CLIA/CAP, you must verify the accuracy of these ungradable results.» This result is designated for regulatory purposes.Peer Group(PG) Codes: AR-all results; AU-all results in specific unit; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument modelProblem Codes: 1(Failure to participate); 2(Failure - Excl Requested); 11(Below Linear/Detection Limit); 22(Above Linear/Detection Limit); 33(Analyzer Out of Service); 66(Specimen Not Appropriate); 88(Testing Suspended During Test Event);
DigitalPT Support from AccuTest Member_DigitalPT International EQA [email protected] | tel 604.222.3900 | fax 604.222.3901 | www.digitalpt.comPO Box 999 Westford, MA, 01886, USA
12 6.660.52
11 18.94-0.14
10 21.35-3.77
12 10.51-1.21
12 2.560.30
18 2.56-0.51
17 9.87-0.23
18 9.60-1.23
18 4.63-0.87
17 1.81-1.20
1 of 3 2011/Feb/25Print Date
Instrument Model: IL GEM Premier 3000
YOUR LAB'S DATAResult Grade Peer Group Code:Description Acceptable Results
Laboratory
Test event
3 / 4
Statistical Count
Mean SD
Blood Gas / Electrolytes (BGAS435) - Performance Report
Laboratory Results Summary
A ACC 4.9 - 6.00.06 1.1
B ACC 4.2 - 5.30.06 1.4
C ACC 5.5 - 6.60.07 1.1
D ACC 3.1 - 4.20.05 1.3
E ACC 6.0 - 7.10.08 1.3
A ACC 143 - 1521.3 0.9
B ACC 135 - 1441.1 0.8
C ACC 147 - 1561.7 1.1
D ACC 125 - 1340.9 0.7
E ACC 151 - 1591.4 0.9
CO1033AI PageLaboratorio Medico Las Americas
CAP LAP Number 7181660
Instrument Nickname: GemSubscription ID 32219 Cycle: 01 - 2011
Results Deadline 2011/Feb/15
Analyte Sample Problem Code
SDICOMPARATIVE GROUP DATA
CV(%)
» Potassium mmol/L
ID:IL GEM Premier 3000 5.4
ID:IL GEM Premier 3000 4.7
ID:IL GEM Premier 3000 6.0
ID:IL GEM Premier 3000 3.7
ID:IL GEM Premier 3000 6.6
Analyte Score: 100.00%
» Sodium mmol/L
ID:IL GEM Premier 3000 145
ID:IL GEM Premier 3000 138
ID:IL GEM Premier 3000 148
ID:IL GEM Premier 3000 129
ID:IL GEM Premier 3000 156
Analyte Score: 100.00%
Grade: ACC - Acceptable; UNACC - Unacceptable; *ACC or *UNACC: Ungradable result due to either lack of peer group consensus or insufficient number of participants. As required by CLIA/CAP, you must verify the accuracy of these ungradable results.» This result is designated for regulatory purposes.Peer Group(PG) Codes: AR-all results; AU-all results in specific unit; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument modelProblem Codes: 1(Failure to participate); 2(Failure - Excl Requested); 11(Below Linear/Detection Limit); 22(Above Linear/Detection Limit); 33(Analyzer Out of Service); 66(Specimen Not Appropriate); 88(Testing Suspended During Test Event);
DigitalPT Support from AccuTest Member_DigitalPT International EQA [email protected] | tel 604.222.3900 | fax 604.222.3901 | www.digitalpt.comPO Box 999 Westford, MA, 01886, USA
27 5.43-0.54
28 4.73-0.39
28 6.02-0.31
28 3.680.38
28 6.560.47
26 147.5-1.95
28 139.2-1.12
26 151.6-2.07
29 129.8-0.84
28 155.00.68
1 of 3 2011/Feb/25Print Date
Instrument Model: IL GEM Premier 3000
YOUR LAB'S DATAResult Grade Peer Group Code:Description Acceptable Results
Laboratory
Test event
4 / 4
Statistical Count
Mean SD
EVALUATIONORIGINAL
HG-A 2011 Hemoglobinopathy Survey
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:3/14/20112/7/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23924136 Kit ID:
Claudia Velasquez MT
Next Mailing Date:8/8/2011
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[26] = Educational challenge.[30] = Scientific committee decision.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 3
P = Based on peer group statistics
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
HG-01 1.9 2.03 0.17 23 -0.7 1.5 2.6 AcceptableHG-02 2.8 2.97 0.26 18 -0.7 [30]HG-03 1.7 1.77 0.11 22 -0.6 1.4 2.2 AcceptableHG-04 2.5 2.51 0.20 24 0.0 1.9 3.2 Acceptable
TestUnit of Measure
Peer Group
Hgb A2, quant%
BIO-RAD D-10
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
HG-A 2011HG-B 2010HG-A 2010
HG-01 8.8 8.98 0.23 24 -0.8 8.2 9.7 AcceptableHgb F, quant%
BIO-RAD D-10HG-A 2011HG-B 2010HG-A 2010
x: Result is outside the acceptable limits
TestMethod Specimen Your Result Intended Response Your Grade
Sickling TestHG-01 NEGATIVELAB PREPARED/IN-HOUSE NEGATIVE Good
HG-02 POSITIVEPOSITIVE Good
HG-03 NEGATIVENEGATIVE Good
HG-04 NEGATIVENEGATIVE Good
Test
Methods
Unit Of Measure--
Hgb Electro, quant %SEBIA CAPILLARYSHB ASEBIA CAPILLARYSHB FSEBIA CAPILLARYSHB A2
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
HG-01 88.9 [26]P 89.16 1.05 46 -0.2
7.0 [26]P 8.44 0.55 45 -2.6
1.9 [26]P 2.10 0.11 44 -1.8
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 3
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239241362/7/20113/14/2011
HG-A 2011 Hemoglobinopathy SurveyE V A L U A T I O NORIGINAL
P = Based on peer group statistics
Test
Methods
Unit Of Measure--
Hgb Electro, quant %SEBIA CAPILLARYSHB FSEBIA CAPILLARYSHB SSEBIA CAPILLARYSHB C
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
HG-02 5.4 [26]P 8.52 0.50 36 -6.2
46.2 [26]P 45.73 2.90 43 +0.2
48.5 [26]P 44.83 1.91 43 +1.9
Hgb Electro, quant %SEBIA CAPILLARYSHB ASEBIA CAPILLARYSHB A2SEBIA CAPILLARYSHB ASEBIA CAPILLARYSHB A2SEBIA CAPILLARYSHB C
HG-03 91.8 [26]P 96.71 2.79 46 -1.8
2.2 [26]P 1.98 0.16 44 +1.4
HG-04 56.9 [26]P 59.47 1.84 45 -1.4
1.6 [26]P 2.42 0.50 37 -1.6
40.3 [26]P 37.17 1.45 43 +2.2
TestMethod Specimen Your Result Intended Response Your Grade
HG-05Dry Lab Challenge ALPHA CHN DELE/MUTATN [26]HG-05 HB HASHARON [26]HG-05 SICKLE SCREEN WILL BE NEG [26]HG-05 CONDITN THAT IS HARMLESS [26]
HG-06 AN ALPHA CHAIN VARIANT [26]HG-06 HIGH O2 AFFINITY HB VARIANT [26]HG-06 HGB G-NORFOLK, TARRANT [26]HG-06 NO THERAPY NEEDED [26]
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 3
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239241362/7/20113/14/2011
HG-A 2011 Hemoglobinopathy SurveyE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
CAR-A 2011 Cardiac Survey Set
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:4/14/20113/15/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23918533 Kit ID:
Claudia Velasquez MT
Next Mailing Date:5/24/2011
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[20] = No appropriate target/response cannot be graded.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 4
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CR-01 0.0 5 [20]CR-02 29.8 7 [20]CR-03 3.7 5 [20]CR-04 66.9 7 [20]CR-05 6.9 6 [20]
TestUnit of Measure
Peer Group
CK-MB, quant, U/LU/L
OTHER
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CR-01 56 49.9 2.5 196 +2.4 34 65 AcceptableCR-02 290 268.0 13.9 196 +1.6 187 349 Acceptable
Myoglobinng/mL or ug/L
BECKMAN ACCESS SYSTEMSCAR-A 2011CAR-C 2010CAR-B 2010
CR-01CR-02
CR-01 0.20 0.303 0.046 217 -2.3 0.16 0.44 AcceptableCR-02 7.14 7.508 0.863 222 -0.4 4.91 10.10 Acceptable
Troponin I, quantng/mL or ug/L
ABBOTT ARCHITECT i
Method/Result
CAR-A 2011CAR-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239185333/15/20114/14/2011
CAR-A 2011 Cardiac Survey SetE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2010 2
Regulated Analyte Test Event Score %
Proficiency Event2010 3
Proficiency Event2011 1 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Pending100C-B 100C-CALT Successful <4>/ /55 5 5Pending100C-B 100C-CAlbumin Successful <4>/ /55 5 5Pending100C-B 100C-CAlkaline Phosphatase Successful <4>/ /55 5 5Pending100C-B 100C-CAmylase Successful <4>/ /55 5 5Pending100C-B 100C-CAST Successful <4>/ /55 5 5Pending100C-B 100C-CBilirubin, Total Successful <4>/ /55 5 5Pending100C-B 100C-CCalcium, Total Successful <4>/ /55 5 5Pending100C-B 100C-CChloride Successful <4>/ /55 5 5Pending100C-B 100C-CCholesterol, Total Successful <4>/ /55 5 5Pending100C-B 100C-CCholesterol, HDL Successful <4>/ /55 5 5Pending100C-B 100C-CCreatine Kinase Successful <4>/ /55 5 5Satisfactory100CAR-B 100CAR-A100CAR-CCK Isoenzymes (CK-MB) Successful/ / /555 5 5 5Pending100C-B 100C-CCreatinine Successful <4>/ /55 5 5Pending100C-B 100C-CGlucose Successful <4>/ /55 5 5Pending100C-B 100C-CIron, Total Successful <4>/ /55 5 5Pending100C-B 100C-CLD Successful <4>/ /55 5 5Pending80C-B 100C-CMagnesium Successful <4>/ /54 5 5Pending100C-B 100C-CPotassium Successful <4>/ /55 5 5Pending100C-B 100C-CSodium Successful <4>/ /55 5 5Pending100C-B 100C-CProtein, Total Successful <4>/ /55 5 5Pending100C-B 100C-CTriglycerides Successful <4>/ /55 5 5Pending100C-B 100C-CUrea Nitrogen Successful <4>/ /55 5 5Pending100C-B 100C-CUric Acid Successful <4>/ /55 5 5
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239185333/15/20114/14/2011
CAR-A 2011 Cardiac Survey SetE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2010 2
Regulated Analyte Test Event Score %
Proficiency Event2010 3
Proficiency Event2011 1 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Routine Chemistry 114/115 99 115/115 100 5/5 Satisfactory Successful
<4> Scorecard performance pending future evaluation or may not be applicable due to discontinued testing or use of a waived method.
100
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239185333/15/20114/14/2011
CAR-A 2011 Cardiac Survey SetE V A L U A T I O NORIGINAL
High Sensitivity C-reactive Protein (HCRP432) - Performance Report
Laboratory Results Summary
A ACC 0 - 3.90.16 19.6
B ACC 8.7 - 14.80.65 5.5
CO1033AI PageLaboratorio Medico Las Americas
CAP LAP Number 7181660
Instrument Nickname: ci8200Subscription ID 32222 Cycle: 01 - 2011
Results Deadline 2011/Mar/15
Analyte Sample Problem Code
SDICOMPARATIVE GROUP DATA
CV(%)
» High Sensitivity C-Reactive Protein mg/L
SM:Turbidimetric (IA) 1.0
SM:Turbidimetric (IA) 11.8
Analyte Score: 100.00%
Grade: ACC - Acceptable; UNACC - Unacceptable; *ACC or *UNACC: Ungradable result due to either lack of peer group consensus or insufficient number of participants. As required by CLIA/CAP, you must verify the accuracy of these ungradable results.» This result is designated for regulatory purposes.Peer Group(PG) Codes: AR-all results; AU-all results in specific unit; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument modelProblem Codes: 1(Failure to participate); 2(Failure - Excl Requested); 11(Below Linear/Detection Limit); 22(Above Linear/Detection Limit); 33(Analyzer Out of Service); 66(Specimen Not Appropriate); 88(Testing Suspended During Test Event);
DigitalPT Support from AccuTest Member_DigitalPT International EQA [email protected] | tel 604.222.3900 | fax 604.222.3901 | www.digitalpt.comPO Box 999 Westford, MA, 01886, USA
27 0.831.01
23 11.760.06
1 of 3 2011/Mar/30Print Date
Instrument Model: Abbott Architect ci8200
YOUR LAB'S DATAResult Grade Peer Group Code:Description Acceptable Results
Laboratory
Test event
3 / 16
Statistical Count
Mean SD
Sweat Testing (SWEA423) - Performance Report
Laboratory Results Summary
A *ACC 67 - 751.2 1.7
B *ACC 117 - 1322.3 1.9
C *ACC 32 - 431.7 4.6
CO1033AI PageLaboratorio Medico Las Americas
CAP LAP Number 7181660
Instrument Nickname: SweatcheckSubscription ID 32225 Cycle: 01 - 2011
Results Deadline 2011/Mar/15
Analyte Sample Problem Code
SDICOMPARATIVE GROUP DATA
CV(%)
» Conductivity mmol/L
SM:Conductivity 73
SM:Conductivity 129
SM:Conductivity 39
Analyte Score: 100.00%
Grade: ACC - Acceptable; UNACC - Unacceptable; *ACC or *UNACC: Ungradable result due to either lack of peer group consensus or insufficient number of participants. As required by CLIA/CAP, you must verify the accuracy of these ungradable results.» This result is designated for regulatory purposes.Peer Group(PG) Codes: AR-all results; AU-all results in specific unit; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument modelProblem Codes: 1(Failure to participate); 2(Failure - Excl Requested); 11(Below Linear/Detection Limit); 22(Above Linear/Detection Limit); 33(Analyzer Out of Service); 66(Specimen Not Appropriate); 88(Testing Suspended During Test Event);
DigitalPT Support from AccuTest Member_DigitalPT International EQA [email protected] | tel 604.222.3900 | fax 604.222.3901 | www.digitalpt.comPO Box 999 Westford, MA, 01886, USA
6 70.71.93
6 124.81.80
6 37.21.06
1 of 2 2011/Mar/30Print Date
Instrument Model: Wescor Sweat-Chek
YOUR LAB'S DATAResult Grade Peer Group Code:Description Acceptable Results
Laboratory
Test event
14 / 16
Statistical Count
Mean SD
EVALUATIONORIGINAL
CSM-A 2011 Immunosuppressive Drugs
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:4/21/20113/7/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23919126 Kit ID:
Claudia Velasquez MT
Next Mailing Date:11/21/2011
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:<NONE>
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 2
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CS-01 195.8 199.16 20.93 19 -0.2 136.3 262.0 AcceptableCS-02 293.7 356.40 33.61 19 -1.9 255.5 457.3 AcceptableCS-03 72.7 78.11 10.86 18 -0.5 45.5 110.8 Acceptable
TestUnit of Measure
Peer Group
Cyclosporineng/mL
ABBOTT AXSYM
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CSM-A 2011CSM-B 2010CSM-A 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 2
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239191263/7/20114/21/2011
CSM-A 2011 Immunosuppressive DrugsE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
C-A 2011 Chemistry
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:4/21/20113/14/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23918173 Kit ID:
Claudia Velasquez MT
Next Mailing Date:5/31/2011
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[11] = Unable to analyze (documentation to be provided by laboratory).[20] = No appropriate target/response cannot be graded.[26] = Educational challenge.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 19
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 100 101.5 2.8 296 -0.5 81 122 AcceptableCHM-02 163 163.6 4.6 293 -0.1 130 197 AcceptableCHM-03 26 26.6 1.8 298 -0.3 21 32 AcceptableCHM-04 207 208.9 6.0 297 -0.3 167 251 AcceptableCHM-05 161 162.9 5.0 296 -0.4 130 196 Acceptable
TestUnit of Measure
Peer Group
ALT (SGPT)U/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010
C-B 2010
CHM-01 3.6 3.56 0.09 130 +0.5 3.2 4.0 AcceptableCHM-02 2.5 2.48 0.07 129 +0.2 2.2 2.8 AcceptableCHM-03 1.7 1.70 0.06 130 +0.1 1.5 1.9 AcceptableCHM-04 3.7 2.74 0.08 127 +12.5 2.4 3.1 UnacceptableCHM-05 2.5 2.49 0.07 129 +0.2 2.2 2.8 Acceptable
Albuming/dL
ABBOTT ARCH C/AEROSETDYE BINDING-BCG
C-A 2011C-C 2010
C-B 2010
x: Result is outside the acceptable limits
CHM-01 129 136.7 5.6 297 -1.4 95 178 AcceptableCHM-02 324 341.9 14.7 295 -1.2 239 445 AcceptableCHM-03 45 46.8 2.1 299 -0.9 32 61 AcceptableCHM-04 425 442.7 20.4 298 -0.9 309 576 AcceptableCHM-05 328 344.5 14.9 298 -1.1 241 448 Acceptable
Alkaline PhosphataseU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-A 2011C-C 2010
C-B 2010
CHM-01 116 116.3 2.3 276 -0.2 81 152 AcceptableCHM-02 232 231.4 4.8 273 +0.1 161 301 AcceptableCHM-03 56 55.4 1.5 275 +0.4 38 72 AcceptableCHM-04 288 289.0 5.5 272 -0.2 202 376 AcceptableCHM-05 231 231.5 4.6 274 -0.1 162 301 Acceptable
Amylase, serumU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-A 2011C-C 2010
C-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 92 89.2 4.9 300 +0.6 71 108 AcceptableCHM-02 181 175.8 8.1 298 +0.6 140 211 AcceptableCHM-03 24 23.7 1.4 297 +0.2 18 29 AcceptableCHM-04 231 225.3 10.9 300 +0.5 180 271 AcceptableCHM-05 181 175.8 8.2 300 +0.6 140 211 Acceptable
TestUnit of Measure
Peer Group
AST (SGOT)U/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010
C-B 2010
CHM-01 1.5 1.42 0.11 246 +0.8 1.0 1.9 AcceptableCHM-02 1.3 1.20 0.07 245 +1.5 0.7 1.6 AcceptableCHM-03 2.6 2.52 0.10 246 +0.8 2.0 3.1 AcceptableCHM-04 0.5 0.54 0.06 249 -0.7 0.1 1.0 AcceptableCHM-05 1.2 1.18 0.07 243 +0.2 0.7 1.6 Acceptable
Bilirubin, directmg/dL
ABBOTT ARCH C/AEROSETDIAZONIUM SALT/ION w/B
C-A 2011C-C 2010
C-B 2010
CHM-01 2.1 2.02 0.17 261 +0.4 1.6 2.5 AcceptableCHM-02 2.0 1.87 0.13 258 +1.0 1.4 2.3 AcceptableCHM-03 5.4 5.15 0.22 255 +1.1 4.1 6.2 AcceptableCHM-04 0.8 0.81 0.09 258 -0.1 0.4 1.3 AcceptableCHM-05 2.0 1.86 0.13 258 +1.1 1.4 2.3 Acceptable
Bilirubin, totalmg/dL
ABBOTT ARCH C/AEROSETDIAZONIUM SALT/ION w/B
C-A 2011C-C 2010
C-B 2010
CHM-01 6.00 6.120 0.094 302 -1.3 5.11 7.12 AcceptableCHM-02 12.20 12.234 0.218 305 -0.2 11.23 13.24 AcceptableCHM-03 9.10 9.228 0.150 303 -0.9 8.22 10.23 AcceptableCHM-04 13.10 13.199 0.258 305 -0.4 12.19 14.20 AcceptableCHM-05 12.10 12.236 0.215 304 -0.6 11.23 13.24 Acceptable
Calcium, serummg/dL
ABBOTT ARCH C/AEROSETARSENAZO III DYE
C-A 2011C-C 2010
C-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 117 116.8 1.2 302 +0.1 110 123 AcceptableCHM-02 91 91.1 1.0 302 -0.1 86 96 AcceptableCHM-03 107 106.4 1.0 298 +0.7 101 112 AcceptableCHM-04 86 86.0 0.9 300 -0.1 81 91 AcceptableCHM-05 91 91.3 0.9 304 -0.3 86 96 Acceptable
TestUnit of Measure
Peer Group
Chloridemmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010
C-B 2010
CHM-01CHM-02CHM-03CHM-04CHM-05CHM-01 240.00 239.560 2.342 279 +0.2 215.60 263.52 AcceptableCHM-02 174.00 174.362 1.874 281 -0.2 156.92 191.80 AcceptableCHM-03 104.00 103.124 1.587 282 +0.6 92.81 113.44 AcceptableCHM-04 199.00 198.388 2.239 281 +0.3 178.54 218.23 AcceptableCHM-05 175.00 174.665 2.006 280 +0.2 157.19 192.14 Acceptable
Cholesterolmg/dL
ABBOTT ARCH C/AEROSETENZYMATIC
Method/Instrument
C-A 2011C-C 2010
C-B 2010
CHM-01 31.1 30.98 2.09 154 +0.1 23.2 38.8 AcceptableCHM-02 12.7 12.72 0.84 152 0.0 9.5 15.9 AcceptableCHM-03 5.5 5.51 0.45 152 0.0 4.1 6.9 AcceptableCHM-04 16.2 15.02 0.98 153 +1.2 11.2 18.8 AcceptableCHM-05 12.6 12.84 0.82 152 -0.3 9.6 16.1 Acceptable
Cortisol, serumug/dL
BECKMAN ACCESS/2C-A 2011C-C 2010
C-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 694 2 [20]CHM-02 164 2 [20]CHM-03 64 2 [20]CHM-04 195 2 [20]CHM-05 163 2 [20]
TestUnit of Measure
Peer Group
Creatine KinaseU/L
OTHER REAGENT/TEMPABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CHM-01 9CHM-02 9CHM-03 9CHM-04 9CHM-05 9CHM-01 0.99 1.008 0.100 168 -0.2 0.70 1.31 AcceptableCHM-02 3.63 3.697 0.117 164 -0.6 3.14 4.26 AcceptableCHM-03 7.32 7.529 0.237 164 -0.9 6.40 8.66 AcceptableCHM-04 2.49 2.455 0.093 164 +0.4 2.08 2.83 AcceptableCHM-05 3.67 3.716 0.131 163 -0.3 3.15 4.28 Acceptable
Creatinine, serummg/dL
ABBOTT ARCH C/AEROSETALK PICRATE w/o LLOYDS
Method Mean
C-A 2011C-C 2010
C-B 2010
CHM-01 56.0 56.15 1.07 275 -0.1 50.1 62.2 AcceptableCHM-02 244.0 245.08 3.62 272 -0.3 220.5 269.6 AcceptableCHM-03 95.0 95.68 1.56 275 -0.4 86.1 105.3 AcceptableCHM-04 290.0 296.64 4.46 273 -1.5 266.9 326.4 AcceptableCHM-05 243.0 245.56 3.66 272 -0.7 221.0 270.2 Acceptable
Glucose, serummg/dL
ABBOTT ARCH C/AEROSETHEXOKINASE, UV
C-A 2011C-C 2010
C-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01CHM-02CHM-03CHM-04CHM-05CHM-01 94.00 96.016 4.316 246 -0.5 67.21 124.83 AcceptableCHM-02 71.00 73.021 3.587 247 -0.6 51.11 94.93 AcceptableCHM-03 42.00 44.943 2.738 251 -1.1 31.46 58.43 AcceptableCHM-04 82.00 82.696 4.101 247 -0.2 57.88 107.51 AcceptableCHM-05 70.00 72.760 3.529 247 -0.8 50.93 94.59 Acceptable
TestUnit of Measure
Peer Group
HDL Cholesterolmg/dL
ABBOTT ARCH C/AEROSETABBOTT ULTRA HDL
Method/Instrument
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010
C-B 2010
CHM-01 727.1 708.69 27.74 185 +0.7 625.4 792.0 AcceptableCHM-02 276.0 273.75 10.93 184 +0.2 240.9 306.6 AcceptableCHM-03 8.1 8.40 0.83 187 -0.4 5.9 10.9 AcceptableCHM-04 381.2 361.30 14.37 184 +1.4 318.1 404.5 AcceptableCHM-05 288.5 273.01 11.01 184 +1.4 239.9 306.1 Acceptable
hCG, serum, quantmIU/mL (IU/L)
ABBOTT ARCHITECT iC-A 2011C-C 2010
C-B 2010
CHM-01 269 256.3 6.4 23 +2.0 205 308 AcceptableCHM-02 138 135.3 2.9 23 +0.9 108 163 AcceptableCHM-03 51 53.3 1.7 22 -1.3 42 64 AcceptableCHM-04 167 162.1 3.2 23 +1.6 129 195 AcceptableCHM-05 139 135.5 2.9 23 +1.2 108 163 Acceptable
Ironug/dL
ABBOTT ARCH C/AEROSETFERENE w/PPR
C-A 2011C-C 2010
C-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 6 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 233 240.6 7.3 263 -1.0 192 289 AcceptableCHM-02 330 343.7 9.7 262 -1.4 274 413 AcceptableCHM-03 121 122.7 5.5 261 -0.3 98 148 AcceptableCHM-04 402 415.4 12.1 261 -1.1 332 499 AcceptableCHM-05 332 344.1 10.0 262 -1.2 275 413 Acceptable
TestUnit of Measure
Peer Group
Lactate DehydrogenaseU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010
C-B 2010
CHM-01 104.60 94.646 19.341 3618 +0.5 [26]CHM-02 79.00 64.970 15.539 3645 +0.9 [26]CHM-03 43.20 36.746 7.324 3595 +0.9 [26]CHM-04 90.40 74.457 18.474 3644 +0.9 [26]CHM-05 80.60 65.067 15.564 3645 +1.0 [26]
LDL Cholesterol, calcmg/dL
CHOL - HDL - (TRIG/5)
CHM-01 [11]CHM-02 [11]CHM-03 [11]CHM-04 [11]CHM-05 [11]
LDL, measured
C-C 2010
C-B 2010
x: Result is outside the acceptable limits
CHM-01 4.9 5.10 0.72 29 -0.3 2.9 7.3 AcceptableCHM-02 3.2 3.62 0.50 28 -0.8 2.1 5.2 AcceptableCHM-03 2.5 2.74 0.56 26 -0.4 1.0 4.5 AcceptableCHM-04 3.8 4.10 0.53 29 -0.6 2.4 5.8 AcceptableCHM-05 3.3 3.59 0.54 28 -0.5 1.9 5.2 Acceptable
Lipoprotein(a)mg/dL
BECKMAN COULTERNEPHELOMETRY
C-A 2011
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 7 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 1CHM-02 1CHM-03 1CHM-04 1CHM-05 1CHM-01 2.88 2.913 0.107 831 -0.3 2.18 3.65 AcceptableCHM-02 2.40 2.417 0.116 830 -0.1 1.81 3.03 AcceptableCHM-03 5.52 5.753 0.264 829 -0.9 4.31 7.20 AcceptableCHM-04 1.20 1.310 0.117 826 -0.9 0.98 1.64 AcceptableCHM-05 2.28 2.416 0.115 825 -1.2 1.81 3.03 Acceptable
TestUnit of Measure
Peer Group
Magnesiummg/dL
ABBOTT ARCH C/AEROSETCOLOR-DYE-XYLIDYL MAGO
Method Mean
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010
C-B 2010
x: Result is outside the acceptable limits
CHM-01 4.5 4.51 0.05 303 -0.3 4.0 5.1 AcceptableCHM-02 3.1 3.09 0.04 302 +0.1 2.5 3.6 AcceptableCHM-03 6.4 6.38 0.07 299 +0.3 5.8 6.9 AcceptableCHM-04 2.0 2.04 0.05 303 -0.8 1.5 2.6 AcceptableCHM-05 3.1 3.09 0.03 297 +0.3 2.5 3.6 Acceptable
Potassium, serummmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
C-A 2011C-C 2010
C-B 2010
CHM-01 5.4 5.51 0.05 294 -2.1 4.9 6.1 AcceptableCHM-02 3.7 3.76 0.06 298 -1.0 3.3 4.2 AcceptableCHM-03 2.5 2.52 0.05 295 -0.5 2.2 2.8 AcceptableCHM-04 4.1 4.17 0.06 297 -1.1 3.7 4.6 AcceptableCHM-05 3.7 3.76 0.06 299 -1.0 3.3 4.2 Acceptable
Protein, total, serumg/dL
ABBOTT ARCH C/AEROSETBIURET
C-A 2011C-C 2010
C-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 8 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 161 160.5 1.2 303 +0.4 156 165 AcceptableCHM-02 121 122.9 1.0 301 -1.8 118 127 AcceptableCHM-03 138 139.1 1.1 296 -1.0 135 144 AcceptableCHM-04 116 117.3 1.0 301 -1.3 113 122 AcceptableCHM-05 122 122.9 1.0 303 -0.9 118 127 Acceptable
TestUnit of Measure
Peer Group
Sodium, serummmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010
C-B 2010
CHM-01 197.00 197.130 3.074 40 0.0 147.84 246.42 AcceptableCHM-02 120.00 120.487 2.204 39 -0.2 90.36 150.61 AcceptableCHM-03 94.00 91.903 2.375 40 +0.9 68.92 114.88 AcceptableCHM-04 133.00 130.963 2.788 40 +0.7 98.22 163.71 AcceptableCHM-05 122.00 120.579 1.886 38 +0.8 90.43 150.73 Acceptable
Triglyceridesmg/dL
ABBOTT ARCH C/AEROSETENZ GPO w/o GB w/SB
C-A 2011C-C 2010
C-B 2010
CHM-01 19.0 19.09 0.44 300 -0.2 17.0 21.1 AcceptableCHM-02 36.0 35.72 0.72 300 +0.4 32.5 39.0 AcceptableCHM-03 11.0 11.13 0.33 297 -0.4 9.1 13.2 AcceptableCHM-04 42.0 43.82 0.87 299 -2.1 39.8 47.8 AcceptableCHM-05 36.0 35.77 0.79 302 +0.3 32.5 39.0 Acceptable
Urea Nitrogen (BUN)mg/dL
ABBOTT ARCH C/AEROSETUREASE WITH GLDH
C-A 2011C-C 2010
C-B 2010
CHM-01 1.9 1.94 0.09 274 -0.4 1.6 2.3 AcceptableCHM-02 11.1 11.18 0.15 279 -0.5 9.2 13.1 AcceptableCHM-03 6.0 5.99 0.11 275 +0.1 4.9 7.1 AcceptableCHM-04 12.9 12.96 0.16 277 -0.4 10.7 15.2 AcceptableCHM-05 11.2 11.20 0.14 277 0.0 9.2 13.2 Acceptable
Uric Acidmg/dL
ABBOTT ARCH C/AEROSETURICASE
C-A 2011C-C 2010
C-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 9 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 391.3 394.82 35.01 62 -0.1 289.7 499.9 AcceptableCHM-02 213.5 214.25 13.23 64 -0.1 174.5 254.0 AcceptableCHM-03 59.9 53.68 8.94 65 +0.7 26.8 80.6 AcceptableCHM-04 248.9 260.19 14.51 64 -0.8 216.6 303.8 AcceptableCHM-05 214.9 213.89 12.60 65 +0.1 176.0 251.7 Acceptable
TestUnit of Measure
Peer Group
Triiodothyronine (T3)ng/dL
ABBOTT ARCHITECT i
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010
C-B 2010
CHM-01 20.5 21.04 3.27 57 -0.2 11.2 30.9 AcceptableCHM-02 8.7 9.15 0.80 64 -0.6 6.7 11.6 AcceptableCHM-03 2.0 1.94 0.21 62 +0.3 1.3 2.6 AcceptableCHM-04 11.7 11.78 1.11 64 -0.1 8.4 15.1 AcceptableCHM-05 8.7 9.17 0.79 64 -0.6 6.8 11.6 Acceptable
T3, freepg/mL
ABBOTT ARCHITECT iC-A 2011C-C 2010
C-B 2010
CHM-01 4.8 5.49 0.34 105 -2.0 4.4 6.6 AcceptableCHM-02 2.6 2.69 0.18 177 -0.5 2.1 3.3 AcceptableCHM-03 1.0 1.03 0.07 176 -0.4 0.8 1.3 AcceptableCHM-04 3.3 3.24 0.23 175 +0.3 2.5 4.0 AcceptableCHM-05 2.6 2.69 0.19 175 -0.5 2.1 3.3 Acceptable
Thyroxine, freeng/dL
ABBOTT ARCHITECT iC-A 2011C-C 2010
C-B 2010
CHM-01 17.5 17.97 1.21 102 -0.4 14.3 21.6 AcceptableCHM-02 7.6 7.83 0.50 101 -0.5 6.2 9.4 AcceptableCHM-03 3.2 3.57 0.38 102 -1.0 2.5 4.6 AcceptableCHM-04 9.2 9.45 0.59 102 -0.4 7.5 11.4 AcceptableCHM-05 7.4 7.85 0.48 99 -0.9 6.2 9.5 Acceptable
Thyroxineug/dL
ABBOTT ARCHITECT iC-A 2011C-C 2010
C-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 10 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 8.04 7.730 0.352 202 +0.9 6.67 8.79 AcceptableCHM-02 0.88 0.850 0.048 205 +0.6 0.70 1.00 AcceptableCHM-03 0.61 0.594 0.037 206 +0.4 0.48 0.71 AcceptableCHM-04 0.98 0.931 0.053 206 +0.9 0.77 1.10 AcceptableCHM-05 0.90 0.848 0.047 204 +1.1 0.70 0.99 Acceptable
TestUnit of Measure
Peer Group
Thyroid Stim HormoneuIU/mL (mIU/L)
ABBOTT ARCHITECT i
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010
C-B 2010
CHM-01 453 266.8 21.2 183 +8.8 [26]CHM-02 307 181.6 15.6 184 +8.0 [26]
Ammoniaumol/L
ABBOTT ARCH C/AEROSETGLUTAMATE DEHYDROGENA
CHM-01 120.00 123.500 8.081 24 -0.4 99.25 147.75 AcceptableCHM-02 85.10 85.478 4.879 23 -0.1 70.84 100.12 Acceptable
Apolipoprotein A1mg/dL
BECKMAN IMMAGEC-A 2011C-C 2010
CHM-01 47.80 46.600 2.236 25 +0.5 39.89 53.31 AcceptableCHM-02 35.00 37.083 3.753 12 -0.6 25.82 48.35 Acceptable
Apolipoprotein Bmg/dL
BECKMAN IMMAGEC-A 2011C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 11 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 6CHM-02 6
CHM-01 0.66 0.701 0.076 837 -0.5 0.47 0.93 AcceptableCHM-02 1.86 1.847 0.107 837 +0.1 1.52 2.17 Acceptable
TestUnit of Measure
Peer Group
Calcium, ionizedmmol/L
OTHER ISE UNDILUTEDOTHER
All Method Principles
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010C-B 2010
CHM-01 [11]CHM-02 [11]
CO2mmol/L
All Method PrinciplesC-C 2010C-B 2010
CHM-01 336 333.2 17.6 123 +0.2 280 387 AcceptableCHM-02 67 64.9 3.0 123 +0.7 56 74 Acceptable
Ferritinng/mL (ug/L)
ABBOTT ARCHITECT iC-A 2011C-C 2010C-B 2010
CHM-01 95 93.9 4.0 229 +0.3 81 106 AcceptableCHM-02 143 140.5 5.8 228 +0.4 123 158 Acceptable
Gamma Glutamyl TransU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-A 2011C-C 2010C-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 12 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 1CHM-02 1
CHM-01 5.5 6.04 0.58 3214 -0.9 4.2 7.8 AcceptableCHM-02 2.5 2.94 0.28 3225 -1.6 2.1 3.8 Acceptable
TestUnit of Measure
Peer Group
Lactatemmol/L
OTHER ISE UNDILUTEDOTHER
All Method Principles
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010C-B 2010
CHM-01 3.70 3.719 0.096 266 -0.2 3.32 4.12 AcceptableCHM-02 2.60 2.649 0.080 267 -0.6 2.34 2.95 Acceptable
Phosphorus, serummg/dL
ABBOTT ARCH C/AEROSETPHOSPHOMOLYBDATE UV
C-A 2011C-C 2010C-B 2010
CHM-01 19.90 19.649 1.210 74 +0.2 14.64 24.65 AcceptableCHM-02 14.00 13.293 0.767 75 +0.9 8.29 18.30 Acceptable
Prealbuminmg/dL
BECKMAN IMMAGEC-A 2011C-C 2010C-B 2010
CHM-01 275 274.3 9.5 35 +0.1 219 330 AcceptableCHM-02 162 176.2 8.1 36 -1.8 140 212 AcceptableCHM-03 111 120.9 5.9 36 -1.7 96 146 AcceptableCHM-04 187 195.7 8.4 35 -1.0 156 235 AcceptableCHM-05 160 176.9 7.9 35 -2.2 141 213 Acceptable
Iron Binding Cap, tot.ug/dL
ABBOTT ARCH C/AEROSETALUMINA ADSORPTION
C-A 2011C-C 2010
C-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 13 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 98 130.7 57.8 1398 -0.6 [26]CHM-02 85 82.0 8.6 1453 +0.3 [26]CHM-03 46 43.9 8.2 1459 +0.3 [26]CHM-04 89 91.9 11.4 1445 -0.3 [26]CHM-05 87 82.1 8.5 1450 +0.6 [26]
TestUnit of Measure
Peer Group
Iron Saturation %%
CALC FROM DIRECT TIBC
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CHM-01 190.00 205.300 13.176 60 -1.2 164.23 246.36 AcceptableCHM-02 132.00 137.541 9.417 61 -0.6 110.03 165.05 AcceptableCHM-03 82.50 96.390 8.230 59 -1.7 77.11 115.67 AcceptableCHM-04 139.00 150.678 9.732 59 -1.2 120.54 180.82 AcceptableCHM-05 135.00 136.417 9.793 60 -0.1 109.13 163.70 Acceptable
Transferrinmg/dL
BECKMAN IMMAGEC-A 2011C-C 2010
C-B 2010
CHM-01 12.6 11.65 0.50 125 +1.9 8.7 14.6 AcceptableCHM-02 15.3 15.48 0.81 126 -0.2 11.6 19.4 AcceptableCHM-03 4.9 5.20 0.24 125 -1.2 3.8 6.5 AcceptableCHM-04 17.4 19.11 0.91 124 -1.9 14.3 23.9 AcceptableCHM-05 15.9 15.55 0.71 125 +0.5 11.6 19.5 Acceptable
Carbamazepineug/mL
ABBOTT AXSYMFPIA
C-A 2011C-C 2010
C-B 2010
CHM-01 2.4 3 [20]CHM-02 1.3 3 [20]CHM-03 0.7 3 [20]CHM-04 1.6 3 [20]CHM-05 1.3 3 [20]
Digoxinng/mL
FPIAABBOTT AXSYM
ORIGINAL REAGENTC-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 14 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 2.6 2.64 0.10 110 -0.4 1.9 3.4 AcceptableCHM-02 3.5 3.58 0.18 115 -0.5 2.6 4.5 AcceptableCHM-03 10.4 10.07 0.79 109 +0.4 7.5 12.6 AcceptableCHM-04 1.2 1.26 0.10 115 -0.6 0.9 1.6 AcceptableCHM-05 3.6 3.58 0.16 114 +0.1 2.6 4.5 Acceptable
TestUnit of Measure
Peer Group
Gentamicinug/mL or mg/L
ABBOTT AXSYMFPIA
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010
C-B 2010
x: Result is outside the acceptable limits
CHM-01 73.1 71.68 4.39 105 +0.3 57.3 86.1 AcceptableCHM-02 32.6 31.92 1.59 107 +0.4 25.5 38.4 AcceptableCHM-03 15.9 15.55 0.71 106 +0.5 12.4 18.7 AcceptableCHM-04 40.4 37.58 2.32 106 +1.2 30.0 45.1 AcceptableCHM-05 33.0 31.99 1.59 105 +0.6 25.5 38.4 Acceptable
Phenobarbitalug/mL
ABBOTT AXSYMFPIA
C-A 2011C-C 2010
C-B 2010
CHM-01 16.1 15.97 0.48 117 +0.3 11.9 20.0 AcceptableCHM-02 26.0 25.43 0.80 118 +0.7 19.0 31.8 AcceptableCHM-03 7.3 6.73 0.22 118 +2.5 5.0 8.5 AcceptableCHM-04 31.9 32.24 1.22 119 -0.3 24.1 40.3 AcceptableCHM-05 28.5 25.48 0.88 117 +3.4 19.1 31.9 Acceptable
Phenytoinug/mL
ABBOTT AXSYMFPIA
C-A 2011C-C 2010
C-B 2010
CHM-01 10.9 11.07 0.38 91 -0.4 8.2 13.9 AcceptableCHM-02 39.9 38.66 1.40 89 +0.9 28.9 48.4 AcceptableCHM-03 21.1 21.88 0.79 91 -1.0 16.4 27.4 AcceptableCHM-04 43.4 44.92 1.86 88 -0.8 33.6 56.2 AcceptableCHM-05 37.9 38.81 1.44 89 -0.6 29.1 48.6 Acceptable
Theophyllineug/mL
ABBOTT AXSYMFPIA
C-A 2011C-C 2010
C-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 15 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-01 104.8 99.63 4.26 112 +1.2 74.7 124.6 AcceptableCHM-02 33.9 35.90 1.67 113 -1.2 26.9 44.9 AcceptableCHM-03 62.1 60.63 2.33 112 +0.6 45.4 75.8 AcceptableCHM-04 28.0 27.93 1.29 112 +0.1 20.9 35.0 AcceptableCHM-05 37.9 36.37 1.62 113 +0.9 27.2 45.5 Acceptable
TestUnit of Measure
Peer Group
Valproic Acidug/mL
ABBOTT AXSYMFPIA
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-A 2011C-C 2010
C-B 2010
CHM-01 46.15 45.730 2.556 111 +0.2 38.06 53.40 AcceptableCHM-02 19.34 20.351 1.095 112 -0.9 17.06 23.64 AcceptableCHM-03 7.19 8.337 0.592 112 -1.9 6.55 10.12 AcceptableCHM-04 22.86 24.623 1.387 112 -1.3 20.46 28.79 AcceptableCHM-05 21.14 20.484 0.987 112 +0.7 17.52 23.45 Acceptable
Vancomycinug/mL or mg/L
ABBOTT AXSYMFPIA
C-A 2011C-C 2010
C-B 2010
CHM-01 [11]CHM-02 [11]
Amikacinug/mL or mg/L
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 16 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2010 2
Regulated Analyte Test Event Score %
Proficiency Event2010 3
Proficiency Event2011 1 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Satisfactory100C-B 100C-A100C-CALT Successful/ / /555 5 5 5Satisfactory100C-B 80C-A100C-CAlbumin Successful/ / /455 5 5 5Satisfactory100C-B 100C-A100C-CAlkaline Phosphatase Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CAmylase Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CAST Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CBilirubin, Total Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CCalcium, Total Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CChloride Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CCholesterol, Total Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CCholesterol, HDL Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CCreatine Kinase Successful/ / /555 5 5 5Satisfactory100CAR-B 100CAR-A100CAR-CCK Isoenzymes (CK-MB) Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CCreatinine Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CGlucose Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CIron, Total Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CLD Successful/ / /555 5 5 5Satisfactory80C-B 100C-A100C-CMagnesium Successful/ / /554 5 5 5Satisfactory100C-B 100C-A100C-CPotassium Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CSodium Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CProtein, Total Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CTriglycerides Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CUrea Nitrogen Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CUric Acid Successful/ / /555 5 5 5
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 17 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2010 2
Regulated Analyte Test Event Score %
Proficiency Event2010 3
Proficiency Event2011 1 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Routine Chemistry 114/115 99 115/115 100 114/115 Satisfactory Successful99
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 18 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 ToxicologyProficiency Event
2010 2
Regulated Analyte Test Event Score %
Proficiency Event2010 3
Proficiency Event2011 1 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Satisfactory100C-B 100C-A100C-CCarbamazepine Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CDigoxin Successful/ / /555 5 5 5Satisfactory80C-B 100C-A100C-CGentamicin Successful/ / /554 5 5 5Satisfactory100C-B 100C-A100C-CPhenobarbital Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CPhenytoin Successful/ / /555 5 5 5 100C-B 100C-CPrimidone Successful/ /55 5 5Satisfactory100C-B 100C-A100C-CTheophylline Successful/ / /555 5 5 5Satisfactory100C-B 100C-A100C-CValproic Acid Successful/ / /555 5 5 5
Toxicology 39/40 98 40/40 100 35/35 Satisfactory Successful100
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 19 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239181733/14/20114/21/2011
C-A 2011 ChemistryE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
CR-A 2011 Cardiac Risk
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:4/27/20113/21/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23920463 Kit ID:
Claudia Velasquez MT
Next Mailing Date:10/31/2011
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:<NONE>
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 2
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
HMS-01 14.2 14.49 0.70 53 -0.4 12.3 16.6 AcceptableHMS-02 5.4 5.67 0.32 52 -0.9 4.7 6.7 AcceptableHMS-03 26.8 26.15 1.08 53 +0.6 22.8 29.5 Acceptable
TestUnit of Measure
Peer Group
Homocysteineumol/L
ABBOTT AXSYMFPIA
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CR-A 2011CR-B 2010CR-A 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 2
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239204633/21/20114/27/2011
CR-A 2011 Cardiac RiskE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
GH2-A 2011 Glycohemoglobin Survey
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:4/22/20114/5/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23920141 Kit ID:
Claudia Velasquez MT
Next Mailing Date:11/8/2011
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:<NONE>
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 2
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
GH2-01 8.0 8.50 7.9 9.1 AcceptableGH2-02 5.5 5.40 5.0 5.8 AcceptableGH2-03 6.6 6.40 5.9 6.9 Acceptable
TestUnit of Measure
Peer Group
Glycohgb HBA1c%
BIO-RAD D-10
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
GH2-A 2011GH2-B 2010GH2-A 2010
GH2-01 8.50GH2-02 5.40GH2-03 6.40
GH2-01 8.0 8.50 7.9 9.1 AcceptableGH2-02 5.5 5.40 5.0 5.8 AcceptableGH2-03 6.6 6.40 6.0 6.8 Acceptable
Glycohgb HBA1c%
BIO-RAD D-10
Educational Grade
GH2-A 2011GH2-B 2010GH2-A 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 2
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239201414/5/20114/22/2011
GH2-A 2011 Glycohemoglobin SurveyE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
M-A 2011 Cerebrospinal Fluid Chemistry
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:5/11/20114/11/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23920766 Kit ID:
Claudia Velasquez MT
Next Mailing Date:9/6/2011
COPIED TO: LAP CAP
IMPORTANT NOTES: Participants Reporting Oligoclonal Bands: Because of spacing limitations on this evaluation report, please note that the result descriptionshave been abbreviated. Please refer to your result form or the PSR for the complete descriptions.
LEGEND: Exception Reason Codes appearing in this evaluation:[20] = No appropriate target/response cannot be graded.[26] = Educational challenge.[27] = Lack of participant or referee consensus.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 3
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
M-01 41 42.0 0.8 23 -1.3 36 48 AcceptableM-02 93 95.7 1.4 23 -2.0 86 106 AcceptableM-03 40 42.1 0.6 23 -3.5 36 49 Acceptable
TestUnit of Measure
Peer Group
Glucose CSFmg/dL
ABBOTT ARCH C/AEROSETHEXOKINASE, COLORIMETR
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
M-A 2011M-B 2010M-A 2010
M-01 21M-02 21M-03 21
M-01 9.1 8.97 0.54 23 +0.2 7.3 10.6 AcceptableM-02 2.0 1.93 0.11 23 +0.7 1.5 2.4 AcceptableM-03 10.3 9.99 0.59 23 +0.5 8.2 11.8 Acceptable
Lactatemmol/L
OTHER MULTI ANALYZEROXIDATION (ELECTRODE)
Method Mean
M-A 2011M-B 2010M-A 2010
M-01 1M-02 1M-03 1
M-01 92.8 112.44 8.74 1713 -2.2 89.9 135.0 AcceptableM-02 42.2 60.66 9.75 1709 -1.9 41.1 80.2 AcceptableM-03 106.8 123.33 8.88 1706 -1.9 98.6 148.0 Acceptable
Protein, Total CSFmg/dL
ABBOTT ARCH C/AEROSETPYROGALLOL RED
Method Mean
M-A 2011M-B 2010M-A 2010
M-01 63.5 66.90 3.13 58 -1.1 53.5 80.3 AcceptableM-02 27.9 31.39 2.62 58 -1.3 25.1 37.7 AcceptableM-03 72.2 76.64 3.16 57 -1.4 61.3 92.0 Acceptable
Albumin (CSF)mg/dL
BECKMAN IMMAGEM-A 2011M-B 2010M-A 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 3
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239207664/11/20115/11/2011
M-A 2011 Cerebrospinal Fluid ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
M-01 221 221.2 10.6 55 0.0 176 266 AcceptableM-02 19 19.5 3.0 52 -0.2 10 29 AcceptableM-03 238 238.6 12.8 56 0.0 190 287 Acceptable
TestUnit of Measure
Peer Group
Lactate DehydrogenaseU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
M-A 2011M-B 2010M-A 2010
M-01 17.1 16.98 0.94 80 +0.1 13.5 20.4 AcceptableM-02 5.9 6.06 0.32 79 -0.5 4.8 7.3 AcceptableM-03 16.5 18.28 1.07 80 -1.7 14.6 22.0 Acceptable
IgG (CSF)mg/dL
BECKMAN IMMAGEM-A 2011M-B 2010M-A 2010
M-01 31 2 [20]M-02 47 2 [20]M-03 33 2 [20]
Albumin Electrophor%
HELENA TITAN GEL
M-01 35 2 [26]M-02 24 2 [26]M-03 35 2 [26]
Gamma Globulin%
HELENA TITAN GEL
TestMethod Specimen Your Result Intended Response Your Grade
Oligoclonal BandsOLI-01HELENA TITAN GEL MATCH OLIGOCLON BND BOTH [27]
OLI-02 OLIGOCLON BANDS ABSENTOLIGOCLON BANDS ABSENT Good
OLI-03 OLIGOCLON BANDS PRESENTOLIGOCLON BANDS PRESENT Good
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 3
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239207664/11/20115/11/2011
M-A 2011 Cerebrospinal Fluid ChemistryE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
ELP-A 2011 Electrophoresis
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:6/14/20114/25/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23925216 Kit ID:
Claudia Velasquez MT
Next Mailing Date:8/8/2011
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[26] = Educational challenge.[27] = Lack of participant or referee consensus.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 5
P = Based on peer group statistics
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
SPE-01 6.5 6.68 0.19 733 -0.9 6.0 7.4 Acceptable
TestUnit of Measure
Peer Group
Protein, Totalg/dL
BIURET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
ELP-A 2011ELP-B 2010ELP-A 2010
Test
Methods
Unit Of Measure--
Albumin Electrophor g/dLSEBIA MINICAP
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
SPE-01 4.4 [26]P 4.50 0.22 28 -0.5Albumin Electrophor %
SEBIA MINICAP SPE-01 67.4 [26]P 67.20 2.16 28 +0.1Alpha 1 Globulin g/dL
SEBIA MINICAP SPE-01 0.3 [26]P 0.34 0.05 29 -0.8Alpha 1 Globulin %
SEBIA MINICAP SPE-01 4.9 [26]P 4.96 0.37 28 -0.2Alpha 2 Globulin g/dL
SEBIA MINICAP SPE-01 0.7 [26]P 0.68 0.05 29 +0.4Alpha 2 Globulin %
SEBIA MINICAP SPE-01 10.2 [26]P 10.22 0.65 28 0.0Beta Globulin g/dL
SEBIA MINICAP SPE-01 0.4 [26]P 0.52 0.09 29 -1.3Beta Globulin %
SEBIA MINICAP SPE-01 6.3 [26]P 7.83 1.08 28 -1.4Total Gamma Globulin g/dL
SEBIA MINICAP SPE-01 0.7 [26]P 0.64 0.09 29 +0.7Total Gamma Globulin %
SEBIA MINICAP SPE-01 11.2 [26]P 9.79 1.05 28 +1.3
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239252164/25/20116/14/2011
ELP-A 2011 ElectrophoresisE V A L U A T I O NORIGINAL
TestMethod Specimen Your Result Intended Response Your Grade
SPE-01SPE Pattern Interp NO ABNORMALITY [27]
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
SPE-01 732 639.5 35.4 111 +2.6 479 800 Acceptable
TestUnit of Measure
Peer Group
Immunoglobulin Gmg/dL
BECKMAN IMMAGE
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
ELP-A 2011ELP-B 2010ELP-A 2010
SPE-01 244 225.7 9.1 110 +2.0 198 253 AcceptableImmunoglobulin Amg/dL
BECKMAN IMMAGEELP-A 2011ELP-B 2010ELP-A 2010
x: Result is outside the acceptable limits
SPE-01 33 37.5 2.7 112 -1.7 29 46 AcceptableImmunoglobulin Mmg/dL
BECKMAN IMMAGEELP-A 2011ELP-B 2010ELP-A 2010
SPE-02 5.9 6.27 0.29 733 -1.3 5.6 6.9 AcceptableProtein, Totalg/dL
BIURETELP-A 2011ELP-B 2010ELP-A 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239252164/25/20116/14/2011
ELP-A 2011 ElectrophoresisE V A L U A T I O NORIGINAL
P = Based on peer group statistics
Test
Methods
Unit Of Measure--
Albumin Electrophor g/dLSEBIA MINICAP
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
SPE-02 2.3 [26]P 2.42 0.12 29 -1.0Albumin Electrophor %
SEBIA MINICAP SPE-02 39.3 [26]P 39.13 0.90 28 +0.2Alpha 1 Globulin g/dL
SEBIA MINICAP SPE-02 0.2 [26]P 0.30 0.04 29 -2.5Alpha 1 Globulin %
SEBIA MINICAP SPE-02 3.7 [26]P 4.86 0.50 28 -2.3Alpha 2 Globulin g/dL
SEBIA MINICAP SPE-02 0.1 [26]P 0.31 0.04 28 -5.3Alpha 2 Globulin %
SEBIA MINICAP SPE-02 1.0 [26]P 4.93 0.56 27 -7.0Beta Globulin g/dL
SEBIA MINICAP SPE-02 0.3 [26]P 2.32 1.28 29 -1.6Beta Globulin %
SEBIA MINICAP SPE-02 5.3 [26]P 36.93 20.71 28 -1.5Total Gamma Globulin g/dL
SEBIA MINICAP SPE-02 3.0 [26]P 0.77 1.21 29 +1.8Total Gamma Globulin %
SEBIA MINICAP SPE-02 50.7 [26]P 12.65 20.10 28 +1.9Paraprotein Peak g/dL
SEBIA MINICAP SPE-02 3.0 [26]P 2.73 0.22 27 +1.2Paraprotein Peak %
SEBIA MINICAP SPE-02 50.7 [26]P 44.22 2.51 27 +2.6Test
Method Specimen Your Result Intended Response Your GradeParaprotein ID
SPE-02 IgA KAPPASEBIA CAPILLARYS IgA KAPPA Good
SPE-02 M-PROTEIN (PARAPROTEIN.)SPE Pattern Interp M-PROTEIN (PARAPROTEIN.) Good
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239252164/25/20116/14/2011
ELP-A 2011 ElectrophoresisE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
SPE-02 72 70.0 4.7 111 +0.4 52 88 Acceptable
TestUnit of Measure
Peer Group
Immunoglobulin Gmg/dL
BECKMAN IMMAGE
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
ELP-A 2011ELP-B 2010ELP-A 2010
SPE-02 3200 2866.5 200.6 113 +1.7 2264 3469 AcceptableImmunoglobulin Amg/dL
BECKMAN IMMAGEELP-A 2011ELP-B 2010ELP-A 2010
x: Result is outside the acceptable limits
SPE-02 8 7.9 0.7 109 +0.1 5 10 AcceptableImmunoglobulin Mmg/dL
BECKMAN IMMAGEELP-A 2011ELP-B 2010ELP-A 2010
TestMethod Specimen Your Result Intended Response Your Grade
Bence Jones Protein IDUBJP-01OTHER NO BENCE JONES PROTEIN [26]
Bence Jones Protein IDUBJP-02OTHER KAPPA FREE LIGHT CHAINS [26]
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239252164/25/20116/14/2011
ELP-A 2011 ElectrophoresisE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
C-B 2011 Chemistry
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:7/8/20115/31/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23918313 Kit ID:
Claudia Velasquez MT
Next Mailing Date:10/3/2011
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[11] = Unable to analyze (documentation to be provided by laboratory).[20] = No appropriate target/response cannot be graded.[26] = Educational challenge.[28] = Response qualified with a greater than or less than sign; or a response is not applicable.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 19
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 77 82.0 2.7 312 -1.8 65 99 AcceptableCHM-07 154 159.5 4.8 310 -1.2 127 192 AcceptableCHM-08 39 44.1 2.2 314 -2.3 35 53 AcceptableCHM-09 96 100.1 3.1 314 -1.3 80 121 AcceptableCHM-10 42 43.9 2.3 314 -0.8 35 53 Acceptable
TestUnit of Measure
Peer Group
ALT (SGPT)U/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011
C-C 2010
CHM-06 3.1 3.12 0.06 134 -0.3 2.8 3.5 AcceptableCHM-07 2.5 2.48 0.05 132 +0.4 2.2 2.8 AcceptableCHM-08 2.2 2.19 0.05 133 +0.3 1.9 2.5 AcceptableCHM-09 3.5 3.56 0.06 135 -0.9 3.2 4.0 AcceptableCHM-10 2.2 2.19 0.05 134 +0.2 1.9 2.5 Acceptable
Albuming/dL
ABBOTT ARCH C/AEROSETDYE BINDING-BCG
C-B 2011C-A 2011
C-C 2010
x: Result is outside the acceptable limits
CHM-06 85 115.2 5.1 315 -5.9 80 150 AcceptableCHM-07 263 353.8 16.4 315 -5.5 247 460 AcceptableCHM-08 52 71.2 2.9 309 -6.6 49 93 AcceptableCHM-09 102 138.4 5.6 311 -6.5 96 180 AcceptableCHM-10 53 71.8 3.1 312 -6.0 50 94 Acceptable
Alkaline PhosphataseU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-B 2011C-A 2011
C-C 2010
CHM-06 105 102.7 2.2 291 +1.1 71 134 AcceptableCHM-07 239 232.7 5.4 289 +1.2 162 303 AcceptableCHM-08 78 75.7 1.9 291 +1.2 53 99 AcceptableCHM-09 119 116.7 2.4 291 +0.9 81 152 AcceptableCHM-10 79 75.7 1.8 289 +1.9 52 99 Acceptable
Amylase, serumU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
C-B 2011C-A 2011
C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 67 69.4 4.1 313 -0.6 55 84 AcceptableCHM-07 164 167.4 8.7 313 -0.4 133 201 AcceptableCHM-08 35 38.4 2.3 314 -1.5 30 47 AcceptableCHM-09 80 83.2 5.0 314 -0.6 66 100 AcceptableCHM-10 37 37.9 2.3 314 -0.4 30 46 Acceptable
TestUnit of Measure
Peer Group
AST (SGOT)U/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011
C-C 2010
CHM-06 2.0 1.80 0.09 266 +2.2 1.4 2.3 AcceptableCHM-07 1.1 1.07 0.07 267 +0.4 0.6 1.5 AcceptableCHM-08 2.9 2.51 0.10 267 +4.0 2.0 3.1 AcceptableCHM-09 1.4 1.28 0.11 267 +1.1 0.8 1.7 AcceptableCHM-10 2.9 2.50 0.09 268 +4.3 1.9 3.0 Acceptable
Bilirubin, directmg/dL
ABBOTT ARCH C/AEROSETDIAZONIUM SALT/ION w/B
C-B 2011C-A 2011
C-C 2010
CHM-06 3.3 2.99 0.18 282 +1.8 2.3 3.6 AcceptableCHM-07 2.1 1.95 0.13 280 +1.1 1.5 2.4 AcceptableCHM-08 4.7 4.23 0.22 283 +2.2 3.3 5.1 AcceptableCHM-09 2.5 2.21 0.18 283 +1.6 1.7 2.7 AcceptableCHM-10 4.6 4.19 0.21 282 +1.9 3.3 5.1 Acceptable
Bilirubin, totalmg/dL
ABBOTT ARCH C/AEROSETDIAZONIUM SALT/ION w/B
C-B 2011C-A 2011
C-C 2010
CHM-06 6.80 6.846 0.098 315 -0.5 5.84 7.85 AcceptableCHM-07 12.20 12.208 0.225 318 0.0 11.20 13.21 AcceptableCHM-08 8.40 8.382 0.119 315 +0.2 7.38 9.39 AcceptableCHM-09 6.10 6.068 0.092 317 +0.3 5.06 7.07 AcceptableCHM-10 8.30 8.384 0.129 319 -0.7 7.38 9.39 Acceptable
Calcium, serummg/dL
ABBOTT ARCH C/AEROSETARSENAZO III DYE
C-B 2011C-A 2011
C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 114 113.9 1.1 318 +0.1 108 120 AcceptableCHM-07 92 90.9 0.8 317 +1.3 86 96 AcceptableCHM-08 108 108.7 1.0 317 -0.7 103 115 AcceptableCHM-09 115 116.5 1.1 316 -1.4 110 123 AcceptableCHM-10 109 108.8 1.0 318 +0.2 103 115 Acceptable
TestUnit of Measure
Peer Group
Chloridemmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011
C-C 2010
CHM-06CHM-07CHM-08CHM-09CHM-10CHM-06 206.00 205.799 2.046 292 +0.1 185.21 226.38 AcceptableCHM-07 173.00 173.346 1.761 291 -0.2 156.01 190.69 AcceptableCHM-08 137.00 137.685 1.718 294 -0.4 123.91 151.46 AcceptableCHM-09 240.00 240.039 2.417 295 0.0 216.03 264.05 AcceptableCHM-10 137.00 137.910 1.894 295 -0.5 124.11 151.71 Acceptable
Cholesterolmg/dL
ABBOTT ARCH C/AEROSETENZYMATIC
Method/Instrument
C-B 2011C-A 2011
C-C 2010
CHM-06 25.4 25.07 1.50 142 +0.2 18.8 31.4 AcceptableCHM-07 12.3 12.72 0.86 144 -0.5 9.5 15.9 AcceptableCHM-08 12.0 12.32 0.80 143 -0.4 9.2 15.5 AcceptableCHM-09 31.3 31.59 1.84 144 -0.2 23.6 39.5 AcceptableCHM-10 12.2 12.34 0.86 145 -0.2 9.2 15.5 Acceptable
Cortisol, serumug/dL
BECKMAN ACCESS/2C-B 2011C-A 2011
C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 522 1 [20]CHM-07 153 1 [20]CHM-08 211 1 [20]CHM-09 682 1 [20]CHM-10 209 1 [20]
TestUnit of Measure
Peer Group
Creatine KinaseU/L
OTHER REAGENT/TEMPABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CHM-06 9CHM-07 9CHM-08 8CHM-09 9CHM-10 8CHM-06 2.60 2.618 0.104 153 -0.2 2.22 3.02 AcceptableCHM-07 3.74 3.709 0.125 151 +0.2 3.15 4.27 AcceptableCHM-08 5.81 5.914 0.194 150 -0.5 5.02 6.81 AcceptableCHM-09 1.01 1.018 0.086 153 -0.1 0.71 1.32 AcceptableCHM-10 5.78 5.922 0.192 149 -0.7 5.03 6.81 Acceptable
Creatinine, serummg/dL
ABBOTT ARCH C/AEROSETALK PICRATE w/o LLOYDS
Method Mean
C-B 2011C-A 2011
C-C 2010
CHM-06 67.0 65.75 1.02 283 +1.2 59.1 72.4 AcceptableCHM-07 247.0 244.69 3.91 281 +0.6 220.2 269.2 AcceptableCHM-08 86.0 85.56 1.20 281 +0.4 77.0 94.2 AcceptableCHM-09 57.0 55.80 0.87 281 +1.4 49.8 61.8 AcceptableCHM-10 88.0 85.53 1.26 282 +2.0 76.9 94.1 Acceptable
Glucose, serummg/dL
ABBOTT ARCH C/AEROSETHEXOKINASE, UV
C-B 2011C-A 2011
C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06CHM-07CHM-08CHM-09CHM-10CHM-06 80.00 82.615 3.646 265 -0.7 57.83 107.40 AcceptableCHM-07 71.00 72.409 3.253 263 -0.4 50.68 94.14 AcceptableCHM-08 55.00 56.650 2.697 265 -0.6 39.65 73.65 AcceptableCHM-09 94.00 95.816 4.034 265 -0.5 67.07 124.57 AcceptableCHM-10 54.00 56.417 2.706 265 -0.9 39.49 73.35 Acceptable
TestUnit of Measure
Peer Group
HDL Cholesterolmg/dL
ABBOTT ARCH C/AEROSETABBOTT ULTRA HDL
Method/Instrument
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011
C-C 2010
CHM-06 524.3 537.97 18.27 203 -0.7 483.1 592.8 AcceptableCHM-07 264.2 272.96 10.65 208 -0.8 241.0 305.0 AcceptableCHM-08 171.2 181.81 8.04 206 -1.3 157.6 206.0 AcceptableCHM-09 715.4 699.54 23.14 206 +0.7 630.1 769.0 AcceptableCHM-10 172.5 182.36 8.05 206 -1.2 158.2 206.6 Acceptable
hCG, serum, quantmIU/mL (IU/L)
ABBOTT ARCHITECT iC-B 2011C-A 2011
C-C 2010
CHM-06 207 206.1 4.9 22 +0.2 164 248 AcceptableCHM-07 133 134.0 3.2 22 -0.3 107 161 AcceptableCHM-08 101 103.5 2.9 22 -0.9 82 125 AcceptableCHM-09 260 256.0 5.7 22 +0.7 204 308 AcceptableCHM-10 103 104.3 2.7 22 -0.5 83 126 Acceptable
Ironug/dL
ABBOTT ARCH C/AEROSETFERENE w/PPR
C-B 2011C-A 2011
C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 6 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 1744 211.3 6.7 271 +228.9 169 254 UnacceptableCHM-07 270 344.3 14.6 272 -5.1 275 414 UnacceptableCHM-08 125 151.7 6.3 271 -4.2 121 182 AcceptableCHM-09 198 240.6 7.6 271 -5.6 192 289 AcceptableCHM-10 125 151.4 5.9 270 -4.4 121 182 Acceptable
TestUnit of Measure
Peer Group
Lactate DehydrogenaseU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011
C-C 2010
x: Result is outside the acceptable limits
CHM-06 91.20 80.522 16.569 3606 +0.6 [26]CHM-07 76.80 65.009 15.824 3607 +0.7 [26]CHM-08 57.60 51.720 10.480 3599 +0.6 [26]CHM-09 105.40 96.382 19.352 3577 +0.5 [26]CHM-10 58.60 52.044 10.604 3597 +0.6 [26]
LDL Cholesterol, calcmg/dL
CHOL - HDL - (TRIG/5)
CHM-06 [11]CHM-07 [11]CHM-08 [11]CHM-09 [11]CHM-10 [11]
LDL, measured
C-C 2010
x: Result is outside the acceptable limits
CHM-06 4.2 4.61 0.38 26 -1.1 3.4 5.8 AcceptableCHM-07 3.1 3.65 0.47 26 -1.2 2.2 5.1 AcceptableCHM-08 2.9 3.24 0.44 26 -0.8 1.9 4.6 AcceptableCHM-09 5.0 5.40 0.66 27 -0.6 3.4 7.4 AcceptableCHM-10 3.3 3.37 0.61 26 -0.1 1.5 5.3 Acceptable
Lipoprotein(a)mg/dL
BECKMAN COULTERNEPHELOMETRY
C-B 2011C-A 2011
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 7 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 1CHM-07 1CHM-08 1CHM-09 1CHM-10 1CHM-06 4.08 3.822 0.160 849 +1.6 2.86 4.78 AcceptableCHM-07 2.52 2.578 0.131 854 -0.4 1.93 3.23 AcceptableCHM-08 5.16 5.244 0.250 844 -0.3 3.93 6.56 AcceptableCHM-09 3.12 3.153 0.156 849 -0.2 2.36 3.95 AcceptableCHM-10 5.04 5.243 0.259 850 -0.8 3.93 6.56 Acceptable
TestUnit of Measure
Peer Group
Magnesiummg/dL
ABBOTT ARCH C/AEROSETCOLOR-DYE-XYLIDYL MAGO
Method Mean
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011
C-C 2010
CHM-06 4.9 4.98 0.04 314 -1.9 4.4 5.5 AcceptableCHM-07 3.1 3.09 0.03 314 +0.3 2.5 3.6 AcceptableCHM-08 5.7 5.91 0.06 311 -3.8 5.4 6.5 AcceptableCHM-09 4.4 4.50 0.04 318 -2.4 4.0 5.1 AcceptableCHM-10 5.8 5.91 0.05 312 -2.1 5.4 6.5 Acceptable
Potassium, serummmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
C-B 2011C-A 2011
C-C 2010
CHM-06 4.5 4.77 0.06 305 -4.5 4.2 5.3 AcceptableCHM-07 3.5 3.73 0.06 306 -4.0 3.3 4.2 AcceptableCHM-08 3.0 3.26 0.06 312 -4.3 2.9 3.6 AcceptableCHM-09 5.3 5.51 0.05 302 -4.1 4.9 6.1 AcceptableCHM-10 3.0 3.26 0.06 313 -4.5 2.9 3.6 Acceptable
Protein, total, serumg/dL
ABBOTT ARCH C/AEROSETBIURET
C-B 2011C-A 2011
C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 8 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 148 151.0 1.1 318 -2.8 146 155 AcceptableCHM-07 119 120.5 1.0 316 -1.5 116 125 AcceptableCHM-08 137 140.4 1.1 319 -3.2 136 145 AcceptableCHM-09 152 155.9 1.2 319 -3.3 151 160 AcceptableCHM-10 138 140.5 1.0 319 -2.4 136 145 Acceptable
TestUnit of Measure
Peer Group
Sodium, serummmol/L
ABBOTT ARCH C/AEROSETION SELECT ELECT DIL
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011
C-C 2010
CHM-06 174.00 172.677 2.403 39 +0.6 129.50 215.85 AcceptableCHM-07 126.00 122.266 1.475 38 +2.5 91.69 152.84 AcceptableCHM-08 122.00 118.887 2.528 39 +1.2 89.16 148.61 AcceptableCHM-09 203.00 200.459 2.883 39 +0.9 150.34 250.58 AcceptableCHM-10 122.00 118.913 2.186 38 +1.4 89.18 148.65 Acceptable
Triglyceridesmg/dL
ABBOTT ARCH C/AEROSETENZ GPO w/o GB w/SB
C-B 2011C-A 2011
C-C 2010
CHM-06 17.0 17.03 0.43 316 -0.1 15.0 19.1 AcceptableCHM-07 36.0 35.77 0.91 317 +0.3 32.5 39.0 AcceptableCHM-08 13.0 13.11 0.38 317 -0.3 11.1 15.2 AcceptableCHM-09 19.0 19.01 0.46 314 0.0 17.0 21.1 AcceptableCHM-10 13.0 13.10 0.37 318 -0.3 11.1 15.2 Acceptable
Urea Nitrogen (BUN)mg/dL
ABBOTT ARCH C/AEROSETUREASE WITH GLDH
C-B 2011C-A 2011
C-C 2010
CHM-06 2.9 2.94 0.10 288 -0.4 2.4 3.5 AcceptableCHM-07 11.2 11.17 0.16 290 +0.2 9.2 13.1 AcceptableCHM-08 4.9 4.98 0.11 289 -0.8 4.1 5.9 AcceptableCHM-09 1.9 1.92 0.09 287 -0.2 1.5 2.3 AcceptableCHM-10 5.0 4.99 0.11 288 +0.1 4.1 5.9 Acceptable
Uric Acidmg/dL
ABBOTT ARCH C/AEROSETURICASE
C-B 2011C-A 2011
C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 9 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 371.7 338.33 28.04 67 +1.2 254.1 422.5 AcceptableCHM-07 213.3 208.28 11.80 68 +0.4 172.8 243.7 AcceptableCHM-08 161.9 160.75 8.36 68 +0.1 135.6 185.9 AcceptableCHM-09 451.7 395.24 35.69 68 +1.6 288.1 502.3 AcceptableCHM-10 161.0 160.81 8.11 68 0.0 136.4 185.2 Acceptable
TestUnit of Measure
Peer Group
Triiodothyronine (T3)ng/dL
ABBOTT ARCHITECT i
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011
C-C 2010
CHM-06CHM-07CHM-08CHM-09CHM-10CHM-06 19.1 16.57 2.25 85 +1.1 9.8 23.4 AcceptableCHM-07 8.3 8.68 0.65 89 -0.6 6.7 10.7 AcceptableCHM-08 5.9 6.27 0.37 87 -1.0 5.1 7.4 AcceptableCHM-09 23.3 20.83 3.40 74 +0.7 10.6 31.1 AcceptableCHM-10 5.7 6.28 0.40 88 -1.5 5.0 7.5 Acceptable
T3, freepg/mL
ABBOTT ARCHITECT i
Method
C-B 2011C-A 2011
C-C 2010
CHM-06 5.4 4.59 0.45 200 +1.8 3.2 6.0 AcceptableCHM-07 2.7 2.67 0.17 202 +0.2 2.1 3.2 AcceptableCHM-08 2.2 2.18 0.15 206 +0.2 1.7 2.7 AcceptableCHM-09 >6.0 5.44 0.34 134 [28]CHM-10 2.2 2.17 0.15 205 +0.2 1.7 2.7 Acceptable
Thyroxine, freeng/dL
ABBOTT ARCHITECT iC-B 2011C-A 2011
C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 10 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 14.1 14.25 0.74 108 -0.2 11.3 17.1 AcceptableCHM-07 6.8 7.70 0.39 108 -2.3 6.1 9.3 AcceptableCHM-08 5.7 6.62 0.40 110 -2.3 5.2 8.0 AcceptableCHM-09 16.5 17.84 1.12 109 -1.2 14.2 21.5 AcceptableCHM-10 5.5 6.63 0.46 109 -2.5 5.3 8.0 Acceptable
TestUnit of Measure
Peer Group
Thyroxineug/dL
ABBOTT ARCHITECT i
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011
C-C 2010
CHM-06 6.23 6.209 0.280 242 +0.1 5.37 7.05 AcceptableCHM-07 0.87 0.872 0.043 239 -0.1 0.74 1.01 AcceptableCHM-08 2.47 2.532 0.118 239 -0.5 2.17 2.89 AcceptableCHM-09 7.88 7.964 0.371 239 -0.2 6.84 9.08 AcceptableCHM-10 2.63 2.523 0.123 238 +0.9 2.15 2.90 Acceptable
Thyroid Stim HormoneuIU/mL (mIU/L)
ABBOTT ARCHITECT iC-B 2011C-A 2011
C-C 2010
CHM-06 403 226.9 17.5 197 +10.1 [26]CHM-07 324 181.2 14.4 197 +9.9 [26]
Ammoniaumol/L
ABBOTT ARCH C/AEROSETGLUTAMATE DEHYDROGENA
CHM-06 121.00 108.364 12.148 22 +1.0 71.91 144.81 AcceptableCHM-07 96.30 87.591 9.762 22 +0.9 58.30 116.88 Acceptable
Apolipoprotein A1mg/dL
BECKMAN IMMAGEC-B 2011C-A 2011C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 11 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 38.90 41.783 2.628 23 -1.1 33.89 49.67 AcceptableCHM-07 35.00 8 [20]
TestUnit of Measure
Peer Group
Apolipoprotein Bmg/dL
BECKMAN IMMAGE
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011C-C 2010
CHM-06 5CHM-07 5
CHM-06 0.83 0.871 0.073 861 -0.6 0.65 1.09 AcceptableCHM-07 1.92 1.845 0.114 861 +0.7 1.50 2.19 Acceptable
Calcium, ionizedmmol/L
OTHER ISE UNDILUTEDOTHER
All Method Principles
C-B 2011C-A 2011C-C 2010
CHM-06 33 27.2 1.7 299 +3.4 22 33 AcceptableCHM-07 18 14.3 1.1 301 +3.2 10 18 Acceptable
CO2mmol/L
ABBOTT ARCH C/AEROSETENZYMATIC
C-B 2011
C-C 2010
CHM-06 287 258.0 12.9 145 +2.2 219 297 AcceptableCHM-07 66 66.6 2.7 145 -0.2 58 75 Acceptable
Ferritinng/mL (ug/L)
ABBOTT ARCHITECT iC-B 2011C-A 2011C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 12 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 78 75.6 3.3 237 +0.7 65 86 AcceptableCHM-07 142 138.4 6.0 239 +0.6 120 157 Acceptable
TestUnit of Measure
Peer Group
Gamma Glutamyl TransU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011C-C 2010
CHM-06CHM-07
CHM-06 4.5 5.05 0.41 3172 -1.3 3.8 6.3 AcceptableCHM-07 2.6 3.03 0.26 3177 -1.7 2.2 3.8 Acceptable
Lactatemmol/L
OTHER ISE UNDILUTEDOTHER
All Method Principles
C-B 2011C-A 2011C-C 2010
CHM-06 4.40 4.288 0.076 280 +1.5 3.82 4.75 AcceptableCHM-07 2.70 2.629 0.070 282 +1.0 2.32 2.93 Acceptable
Phosphorus, serummg/dL
ABBOTT ARCH C/AEROSETPHOSPHOMOLYBDATE UV
C-B 2011C-A 2011C-C 2010
CHM-06 14.00 16.727 1.034 77 -2.6 11.72 21.73 AcceptableCHM-07 12.80 12.857 0.738 77 -0.1 7.85 17.86 Acceptable
Prealbuminmg/dL
BECKMAN IMMAGEC-B 2011C-A 2011C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 13 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 241 241.9 11.7 33 -0.1 193 291 AcceptableCHM-07 179 179.4 6.8 32 -0.1 143 216 AcceptableCHM-08 162 161.7 9.7 33 0.0 129 195 AcceptableCHM-09 286 281.1 9.3 33 +0.5 224 338 AcceptableCHM-10 158 161.3 10.3 33 -0.3 129 194 Acceptable
TestUnit of Measure
Peer Group
Iron Binding Cap, tot.ug/dL
ABBOTT ARCH C/AEROSETALUMINA ADSORPTION
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011
C-C 2010
CHM-06 86 109.5 29.1 1417 -0.8 [26]CHM-07 74 80.9 7.7 1436 -0.9 [26]CHM-08 62 69.7 7.4 1434 -1.0 [26]CHM-09 91 130.7 57.2 1392 -0.7 [26]CHM-10 65 69.7 7.3 1429 -0.6 [26]
Iron Saturation %%
CALC FROM DIRECT TIBC
CHM-06 146.00 180.140 12.703 57 -2.7 144.11 216.17 AcceptableCHM-07 121.00 138.724 9.635 58 -1.8 110.97 166.47 AcceptableCHM-08 105.00 122.724 9.989 58 -1.8 98.17 147.27 AcceptableCHM-09 173.00 202.947 11.398 57 -2.6 162.35 243.54 AcceptableCHM-10 102.00 120.448 8.234 58 -2.2 96.35 144.54 Acceptable
Transferrinmg/dL
BECKMAN IMMAGEC-B 2011C-A 2011
C-C 2010
CHM-06 9.9 10.14 0.45 116 -0.5 7.6 12.7 AcceptableCHM-07 15.0 15.42 0.74 118 -0.6 11.5 19.3 AcceptableCHM-08 6.8 6.90 0.27 116 -0.4 5.1 8.7 AcceptableCHM-09 12.7 11.79 0.55 117 +1.7 8.8 14.8 AcceptableCHM-10 6.9 6.87 0.30 117 +0.1 5.1 8.6 Acceptable
Carbamazepineug/mL
ABBOTT AXSYMFPIA
C-B 2011C-A 2011
C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 14 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06CHM-07CHM-08CHM-09CHM-10CHM-06 2.1 2.38 0.24 23 -1.2 1.9 2.9 AcceptableCHM-07 1.3 1.42 0.17 23 -0.7 1.1 1.8 AcceptableCHM-08 1.1 1.28 0.16 23 -1.1 1.0 1.6 AcceptableCHM-09 2.7 2.90 0.32 23 -0.6 2.3 3.5 AcceptableCHM-10 1.1 1.27 0.16 23 -1.0 1.0 1.6 Acceptable
TestUnit of Measure
Peer Group
Digoxinng/mL
ABBOTT AXSYMFPIA
Method Mean
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011
CHM-06 4.4 4.70 0.18 105 -1.7 3.5 5.9 AcceptableCHM-07 3.3 3.54 0.14 106 -1.7 2.6 4.5 AcceptableCHM-08 8.3 8.39 0.41 106 -0.2 6.2 10.5 AcceptableCHM-09 2.5 2.65 0.15 106 -1.0 1.9 3.4 AcceptableCHM-10 8.1 8.41 0.48 106 -0.6 6.3 10.6 Acceptable
Gentamicinug/mL or mg/L
ABBOTT AXSYMFPIA
C-B 2011C-A 2011
C-C 2010
CHM-06 64.8 57.15 4.30 101 +1.8 45.7 68.6 AcceptableCHM-07 32.7 31.52 1.62 100 +0.7 25.2 37.9 AcceptableCHM-08 29.4 28.78 1.33 101 +0.5 23.0 34.6 AcceptableCHM-09 74.8 72.48 5.05 101 +0.5 57.9 87.0 AcceptableCHM-10 28.6 28.72 1.71 101 -0.1 22.9 34.5 Acceptable
Phenobarbitalug/mL
ABBOTT AXSYMFPIA
C-B 2011C-A 2011
C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 15 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CHM-06 14.6 13.84 0.40 106 +1.9 10.3 17.4 AcceptableCHM-07 25.4 25.42 0.86 106 0.0 19.0 31.8 AcceptableCHM-08 9.5 9.29 0.29 108 +0.7 6.9 11.7 AcceptableCHM-09 16.6 16.09 0.46 106 +1.1 12.0 20.2 AcceptableCHM-10 9.4 9.30 0.28 105 +0.4 6.9 11.7 Acceptable
TestUnit of Measure
Peer Group
Phenytoinug/mL
ABBOTT AXSYMFPIA
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
C-B 2011C-A 2011
C-C 2010
CHM-06 13.7 13.68 0.41 87 0.0 10.2 17.1 AcceptableCHM-07 34.6 38.70 1.28 84 -3.2 29.0 48.4 AcceptableCHM-08 19.1 19.14 0.71 85 -0.1 14.3 24.0 AcceptableCHM-09 10.7 11.07 0.35 85 -1.1 8.2 13.9 AcceptableCHM-10 18.9 19.21 0.64 84 -0.5 14.4 24.1 Acceptable
Theophyllineug/mL
ABBOTT AXSYMFPIA
C-B 2011C-A 2011
C-C 2010
CHM-06 85.5 89.72 3.91 106 -1.1 67.2 112.2 AcceptableCHM-07 34.4 35.93 1.72 106 -0.9 26.9 45.0 AcceptableCHM-08 68.4 71.01 2.82 104 -0.9 53.2 88.8 AcceptableCHM-09 95.3 100.52 3.75 105 -1.4 75.3 125.7 AcceptableCHM-10 70.0 70.98 2.75 104 -0.4 53.2 88.8 Acceptable
Valproic Acidug/mL
ABBOTT AXSYMFPIA
C-B 2011C-A 2011
C-C 2010
CHM-06 32.81 36.716 1.986 103 -2.0 30.75 42.68 AcceptableCHM-07 19.08 20.361 1.035 102 -1.2 17.25 23.47 AcceptableCHM-08 17.72 17.959 0.972 101 -0.2 15.04 20.88 AcceptableCHM-09 46.04 46.158 2.468 101 0.0 38.75 53.57 AcceptableCHM-10 17.82 17.749 1.056 103 +0.1 14.58 20.92 Acceptable
Vancomycinug/mL or mg/L
ABBOTT AXSYMFPIA
C-B 2011C-A 2011
C-C 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 16 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2010 3
Regulated Analyte Test Event Score %
Proficiency Event2011 1
Proficiency Event2011 2 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Satisfactory100C-C 100C-B100C-AALT Successful/ / /555 5 5 5Satisfactory100C-C 100C-B80C-AAlbumin Successful/ / /555 4 5 5Satisfactory100C-C 100C-B100C-AAlkaline Phosphatase Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AAmylase Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AAST Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ABilirubin, Total Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ACalcium, Total Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AChloride Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ACholesterol, Total Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ACholesterol, HDL Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ACreatine Kinase Successful/ / /555 5 5 5Satisfactory100CAR-C 100CAR-B100CAR-ACK Isoenzymes (CK-MB) Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ACreatinine Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AGlucose Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AIron, Total Successful/ / /555 5 5 5Unsatisfactory100C-C 60C-B100C-ALD Successful <2>/ / /355 5 5 5Satisfactory100C-C 100C-B100C-AMagnesium Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-APotassium Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ASodium Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AProtein, Total Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ATriglycerides Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AUrea Nitrogen Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AUric Acid Successful/ / /555 5 5 5
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 17 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2010 3
Regulated Analyte Test Event Score %
Proficiency Event2011 1
Proficiency Event2011 2 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Routine Chemistry 115/115 100 114/115 99 113/115 Satisfactory Successful
<2> Currently successful - At risk for the next two mailings.
98
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 18 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
Subspecialty :7181660 ToxicologyProficiency Event
2010 3
Regulated Analyte Test Event Score %
Proficiency Event2011 1
Proficiency Event2011 2 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Satisfactory100C-C 100C-B100C-ACarbamazepine Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-ADigoxin Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AGentamicin Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-APhenobarbital Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-APhenytoin Successful/ / /555 5 5 5 100C-CPrimidone Successful/55Satisfactory100C-C 100C-B100C-ATheophylline Successful/ / /555 5 5 5Satisfactory100C-C 100C-B100C-AValproic Acid Successful/ / /555 5 5 5
Toxicology 40/40 100 35/35 100 35/35 Satisfactory Successful100
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 19 of 19
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239183135/31/20117/8/2011
C-B 2011 ChemistryE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
CAR-B 2011 Cardiac Survey Set
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:7/8/20115/24/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23918608 Kit ID:
Claudia Velasquez MT
Next Mailing Date:10/4/2011
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[11] = Unable to analyze (documentation to be provided by laboratory).[20] = No appropriate target/response cannot be graded.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 4
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
CR-06 4.8 8 [20]CR-07 11.2 11 [20]CR-08 38.3 11 [20]CR-09 7.5 9 [20]CR-10 10.5 10 [20]
TestUnit of Measure
Peer Group
CK-MB, quant, U/LU/L
OTHER
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
CR-06 [11]CR-07 [11]
Myoglobinng/mL or ug/L CAR-A 2011
CAR-C 2010
CR-06CR-07
CR-06 0.31 0.466 0.038 232 -4.1 0.32 0.61 UnacceptableCR-07 0.66 1.036 0.079 231 -4.8 0.72 1.35 Unacceptable
Troponin I, quantng/mL or ug/L
ABBOTT ARCHITECT i
Method/Result
CAR-B 2011CAR-A 2011CAR-C 2010
x: Result is outside the acceptable limits
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239186085/24/20117/8/2011
CAR-B 2011 Cardiac Survey SetE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2010 3
Regulated Analyte Test Event Score %
Proficiency Event2011 1
Proficiency Event2011 2 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
100C-C 100C-AALT Successful/ /55 5 5 100C-C 80C-AAlbumin Successful/ /55 4 5 100C-C 100C-AAlkaline Phosphatase Successful/ /55 5 5 100C-C 100C-AAmylase Successful/ /55 5 5 100C-C 100C-AAST Successful/ /55 5 5 100C-C 100C-ABilirubin, Total Successful/ /55 5 5 100C-C 100C-ACalcium, Total Successful/ /55 5 5 100C-C 100C-AChloride Successful/ /55 5 5 100C-C 100C-ACholesterol, Total Successful/ /55 5 5 100C-C 100C-ACholesterol, HDL Successful/ /55 5 5 100C-C 100C-ACreatine Kinase Successful/ /55 5 5Satisfactory100CAR-C 100CAR-B100CAR-ACK Isoenzymes (CK-MB) Successful/ / /555 5 5 5 100C-C 100C-ACreatinine Successful/ /55 5 5 100C-C 100C-AGlucose Successful/ /55 5 5 100C-C 100C-AIron, Total Successful/ /55 5 5 100C-C 100C-ALD Successful/ /55 5 5 100C-C 100C-AMagnesium Successful/ /55 5 5 100C-C 100C-APotassium Successful/ /55 5 5 100C-C 100C-ASodium Successful/ /55 5 5 100C-C 100C-AProtein, Total Successful/ /55 5 5 100C-C 100C-ATriglycerides Successful/ /55 5 5 100C-C 100C-AUrea Nitrogen Successful/ /55 5 5 100C-C 100C-AUric Acid Successful/ /55 5 5
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239186085/24/20117/8/2011
CAR-B 2011 Cardiac Survey SetE V A L U A T I O NORIGINAL
Subspecialty :7181660 Routine ChemistryProficiency Event
2010 3
Regulated Analyte Test Event Score %
Proficiency Event2011 1
Proficiency Event2011 2 Cumulative CLIA
'88 PerformanceInterpretation
Current EventPerformanceInterpretationTest Event Score % Test Event Score %
CAP
CAP #:
Routine Chemistry 115/115 100 114/115 99 5/5 Satisfactory Successful100
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239186085/24/20117/8/2011
CAR-B 2011 Cardiac Survey SetE V A L U A T I O NORIGINAL
High Sensitivity C-reactive Protein (HCRP432) - Performance Report
Laboratory Results Summary
A ACC 0 - 3.80.12 16.2
B ACC 11.3 - 17.30.96 6.7
CO1033AI PageLaboratorio Medico Las Americas
CAP LAP Number 7181660
Instrument Nickname: ci8200Subscription ID 32222 Cycle: 02 - 2011
Results Deadline 2011/Jun/28
Analyte Sample Problem Code
SDICOMPARATIVE GROUP DATA
CV(%)
» High Sensitivity C-Reactive Protein mg/L
SM:Turbidimetric (IA) 0.8
SM:Turbidimetric (IA) 13.6
Analyte Score: 100.00%
Grade: ACC - Acceptable; UNACC - Unacceptable; *ACC or *UNACC: Ungradable result due to either lack of peer group consensus or insufficient number of participants. As required by CLIA/CAP, you must verify the accuracy of these ungradable results.» This result is designated for regulatory purposes.Peer Group(PG) Codes: AR-all results; AU-all results in specific unit; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument modelProblem Codes: 1(Failure to participate); 2(Failure - Excl Requested); 11(Below Linear/Detection Limit); 22(Above Linear/Detection Limit); 33(Analyzer Out of Service); 66(Specimen Not Appropriate); 88(Testing Suspended During Test Event);
DigitalPT Support from AccuTest Member_DigitalPT International EQA [email protected] | tel 604.222.3900 | fax 604.222.3901 | www.digitalpt.comPO Box 999 Westford, MA, 01886, USA
26 0.730.60
22 14.30-0.72
2 of 3 2011/Jul/15Print Date
Instrument Model: Abbott Architect ci8200
YOUR LAB'S DATAResult Grade Peer Group Code:Description Acceptable Results
Laboratory
Test event
3 / 14
Statistical Count
Mean SD
EVALUATIONORIGINAL
U-B 2011 Urine Chemistry-Genl
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:8/20/20117/11/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23921569 Kit ID:
Claudia Velasquez MT
Next Mailing Date:1/9/2012
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[28] = Response qualified with a greater than or less than sign; or a response is not applicable.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 5
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-07 67.70 74.411 6.276 129 -1.1 51.34 97.48 AcceptableU-08 69.80 67.646 6.049 129 +0.4 46.67 88.62 AcceptableU-09 18.50 18.216 0.331 137 +0.9 12.56 23.87 Acceptable
TestUnit of Measure
Peer Group
Calcium, urinemg/dL
ABBOTT ARCH C/AEROSETARSENAZO III DYE
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-B 2011U-A 2011U-B 2010
x: Result is outside the acceptable limitsU-07 43.0 43.26 0.79 80 -0.3 34.6 52.0 AcceptableU-08 44.0 44.84 0.83 80 -1.0 35.8 53.9 AcceptableU-09 81.0 80.14 1.34 81 +0.6 64.1 96.2 Acceptable
Glucose, urinemg/dL
ABBOTT ARCH C/AEROSETHEXOKINASE, UV
U-B 2011U-A 2011U-B 2010
U-07 1U-08 1U-09 1
U-07 17.4 19.61 1.22 1440 -1.8 14.7 24.6 AcceptableU-08 24.6 25.93 1.75 1422 -0.8 19.4 32.5 AcceptableU-09 5.9 7.14 0.45 1450 -2.8 5.3 9.0 Acceptable
Magnesium, urinemg/dL
ABBOTT ARCH C/AEROSETCOLOR-DYE-XYLIDYL MAGO
All Methods/All Instruments
U-B 2011U-A 2011U-B 2010
U-07 89.52 94.732 1.786 154 -2.9 78.62 110.84 AcceptableU-08 48.92 49.465 0.934 153 -0.6 41.05 57.88 AcceptableU-09 46.42 47.453 0.790 151 -1.3 39.38 55.52 Acceptable
Creatininemg/dL
ABBOTT ARCH C/AEROSETKINETIC ALK. PICRATE
U-B 2011U-A 2011U-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239215697/11/20118/20/2011
U-B 2011 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-07 43.40 43.435 0.887 97 0.0 33.44 53.43 AcceptableU-08 47.10 46.187 0.834 95 +1.1 35.56 56.82 AcceptableU-09 138.10 137.576 2.965 98 +0.2 105.93 169.22 Acceptable
TestUnit of Measure
Peer Group
Phosphorus, urinemg/dL
ABBOTT ARCH C/AEROSETPHOSPHOMOLYBDATE UV
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-B 2011U-A 2011U-B 2010
U-07 114 119.9 1.9 174 -3.1 85 155 AcceptableU-08 9 9.2 0.4 176 -0.5 6 12 AcceptableU-09 119 125.4 2.1 175 -3.0 89 162 Acceptable
Potassium, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
U-B 2011U-A 2011U-B 2010
U-10 90 83.7 1.2 161 +5.3 61 106 AcceptableU-11 <20 17.9 2.4 15 [28]U-12 124 119.2 1.7 163 +2.8 88 151 Acceptable
Chloride, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
U-B 2011U-A 2011U-B 2010
U-10 1.1 1.31 0.10 61 -2.1 0.9 1.7 AcceptableU-11 88.7 100.58 7.55 63 -1.6 70.4 130.8 AcceptableU-12 2.3 2.67 0.21 63 -1.8 1.8 3.5 Acceptable
Urine albuminmg/dL
BECKMAN IMMAGENEPHELOMETRY
U-B 2011U-A 2011
U-10 83.11 85.861 1.745 153 -1.6 71.26 100.46 AcceptableU-11 56.73 59.460 1.271 155 -2.1 49.35 69.57 AcceptableU-12 27.18 27.588 0.650 151 -0.6 22.89 32.28 Acceptable
Creatinine, urinemg/dL
ABBOTT ARCH C/AEROSETKINETIC ALK. PICRATE
U-B 2011U-A 2011U-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239215697/11/20118/20/2011
U-B 2011 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-10 1U-11 1U-12 1
U-10 692.0 668.31 36.97 2194 +0.6 527.9 808.7 AcceptableU-11 498.0 502.73 29.81 2202 -0.2 397.1 608.3 AcceptableU-12 776.0 792.89 42.53 2196 -0.4 626.3 959.4 Acceptable
TestUnit of Measure
Peer Group
Urea nitrogen, urinemg/dL
ABBOTT ARCH C/AEROSETOTHER
All Methods/All Instruments
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-B 2011U-A 2011U-B 2010
U-10 13.20 12.571 0.660 119 +1.0 9.55 15.59 AcceptableU-11 23.60 23.864 0.902 122 -0.3 18.13 29.60 AcceptableU-12 22.80 23.110 0.804 122 -0.4 17.56 28.66 Acceptable
Uric Acid, urinemg/dL
ABBOTT ARCH C/AEROSETURICASE
U-B 2011U-A 2011U-B 2010
U-10 150 156.8 4.7 125 -1.4 142 171 AcceptableU-11 135 136.6 3.8 123 -0.4 125 148 AcceptableU-12 237 231.5 7.2 126 +0.8 209 254 Acceptable
Amylase, urineU/L
ABBOTT/37 CABBOTT ARCH C/AEROSET
U-B 2011U-A 2011U-B 2010
U-07 59.10 61.424 1.598 151 -1.5 34.39 88.46 AcceptableU-08 6.80 5.962 1.629 53 +0.5 3.33 8.59 AcceptableU-09 103.60 104.342 2.527 152 -0.3 58.43 150.26 Acceptable
Protein, Totalmg/dL
ABBOTT ARCH C/AEROSETBENZETHONIUM CHLORIDE
U-B 2011U-A 2011U-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239215697/11/20118/20/2011
U-B 2011 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
U-10 101 104.5 1.6 178 -2.2 77 132 AcceptableU-11 26 24.4 1.4 176 +1.2 18 31 AcceptableU-12 44 42.7 1.1 178 +1.1 31 54 Acceptable
TestUnit of Measure
Peer Group
Sodium, urinemmol/L
ABBOTT ARCH C/AEROSETION SELECTIVE ELECTROD
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
U-B 2011U-A 2011U-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239215697/11/20118/20/2011
U-B 2011 Urine Chemistry-GenlE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
HG-B 2011 Hemoglobinopathy Survey
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:9/13/20118/8/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23924147 Kit ID:
Claudia Velasquez MT
Next Mailing Date:2/6/2012
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[11] = Unable to analyze (documentation to be provided by laboratory).[26] = Educational challenge.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 4
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
HG-07 2.3 2.08 0.13 33 +1.7 1.6 2.5 AcceptableHG-08 2.6 2.35 0.12 32 +2.0 1.9 2.8 AcceptableHG-09 2.5 2.26 0.13 31 +1.9 1.8 2.7 AcceptableHG-10 2.0 1.88 0.11 32 +1.1 1.5 2.3 Acceptable
TestUnit of Measure
Peer Group
Hgb A2, quant%
BIO-RAD D-10
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
HG-B 2011HG-A 2011HG-B 2010
HG-07 1.7 1.96 0.17 34 -1.5 1.4 2.5 AcceptableHgb F, quant%
BIO-RAD D-10HG-B 2011HG-A 2011HG-B 2010
TestMethod Specimen Your Result Intended Response Your Grade
Sickling TestHG-07 NEGATIVELAB PREPARED/IN-HOUSE NEGATIVE Good
HG-08 NEGATIVENEGATIVE Good
HG-09 POSITIVEPOSITIVE Good
HG-10 NEGATIVENEGATIVE Good
TestSpecimen Your GradeAcceptable ResponseMethod Your Result Good Response
Hgb Electro Alk only
HG-07 [11]
HG-08 [11]
HG-09 [11]
HG-10 [11]
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239241478/8/20119/13/2011
HG-B 2011 Hemoglobinopathy SurveyE V A L U A T I O NORIGINAL
P = Based on peer group statistics
TestSpecimen Your GradeAcceptable ResponseMethod Your Result Good Response
Test
Methods
Unit Of Measure--
Hgb Electro, quant %SEBIA MINICAPHB ASEBIA MINICAPHB A2SEBIA MINICAPHB ASEBIA MINICAPHB A2SEBIA MINICAPHB CSEBIA MINICAPHB ASEBIA MINICAPHB FSEBIA MINICAPHB SSEBIA MINICAPHB A2SEBIA MINICAPHB ASEBIA MINICAPHB A2
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
HG-07 97.7 [26]P 97.78 0.15 16 -0.5
2.3 [26]P 2.24 0.14 17 +0.4
HG-08 63.7 [26]P 63.28 2.49 18 +0.2
1.0 [26]P 2.24 0.59 12 -2.1
35.0 [26]P 34.46 1.72 16 +0.3
HG-09 58.4 [26]P 60.25 1.33 16 -1.4
2.4 [26]P 1.75 0.41 15 +1.6
35.8 [26]P 35.26 1.18 16 +0.5
2.0 [26]P 2.28 0.17 16 -1.6
HG-10 96.8 [26]P 97.79 0.40 16 -2.5
2.0 [26]P 2.01 0.15 17 -0.1
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239241478/8/20119/13/2011
HG-B 2011 Hemoglobinopathy SurveyE V A L U A T I O NORIGINAL
TestMethod Specimen Your Result Intended Response Your Grade
HG-11Dry Lab Challenge BETA CHAIN MUTATION [26]HG-11 HB J [26]HG-11 HARMLESS CONDITION [26]
HG-12 BETA CHAIN MUTATION [26]HG-12 HB N [26]HG-12 HARMLESS CONDITION [26]
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 4
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239241478/8/20119/13/2011
HG-B 2011 Hemoglobinopathy SurveyE V A L U A T I O NORIGINAL
EVALUATIONORIGINAL
ELP-B 2011 Electrophoresis
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:9/19/20118/8/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23925233 Kit ID:
Claudia Velasquez MT
Next Mailing Date:4/23/2012
COPIED TO: LAP CAP
LEGEND: Exception Reason Codes appearing in this evaluation:[11] = Unable to analyze (documentation to be provided by laboratory).[26] = Educational challenge.[28] = Response qualified with a greater than or less than sign; or a response is not applicable.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 5
P = Based on peer group statistics
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
SPE-03 5.8 5.99 0.23 733 -0.8 5.3 6.6 Acceptable
TestUnit of Measure
Peer Group
Protein, Totalg/dL
BIURET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
ELP-B 2011ELP-A 2011ELP-B 2010
Test
Methods
Unit Of Measure--
Albumin Electrophor g/dLSEBIA MINICAP
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
SPE-03 1.3 [26]P 1.44 0.07 34 -2.0Albumin Electrophor %
SEBIA MINICAP SPE-03 23.0 [26]P 24.10 0.91 29 -1.2Alpha 1 Globulin g/dL
SEBIA MINICAP SPE-03 0.1 [26]P 0.17 0.04 34 -1.8Alpha 1 Globulin %
SEBIA MINICAP SPE-03 2.4 [26]P 2.72 0.36 30 -0.9Alpha 2 Globulin g/dL
SEBIA MINICAP SPE-03 0.3 [26]P 0.29 0.04 34 +0.3Alpha 2 Globulin %
SEBIA MINICAP SPE-03 4.6 [26]P 4.54 0.37 29 +0.2Beta Globulin g/dL
SEBIA MINICAP SPE-03 3.9 [26]P 2.82 1.74 34 +0.6Beta Globulin %
SEBIA MINICAP SPE-03 67.8 [26]P 46.07 28.90 30 +0.8Total Gamma Globulin g/dL
SEBIA MINICAP SPE-03 0.1 [26]P 1.31 1.65 34 -0.7Total Gamma Globulin %
SEBIA MINICAP SPE-03 2.2 [26]P 22.71 28.76 30 -0.7Paraprotein Peak g/dL
SEBIA MINICAP SPE-03 3.9 [26]P 3.55 0.28 31 +1.3
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239252338/8/20119/19/2011
ELP-B 2011 ElectrophoresisE V A L U A T I O NORIGINAL
P = Based on peer group statistics
Test
Methods
Unit Of Measure--
Paraprotein Peak %SEBIA MINICAP
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
SPE-03 67.8 [26]P 59.57 2.33 27 +3.5Test
Method Specimen Your Result Intended Response Your GradeParaprotein ID
SPE-03 IgA LAMBDASEBIA CAPILLARYS IgA LAMBDA Good
SPE-03 M-PROTEIN (PARAPROTEIN.)SPE Pattern Interp M-PROTEIN (PARAPROTEIN.) Good
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
SPE-03 207 204.0 12.0 103 +0.3 152 255 Acceptable
TestUnit of Measure
Peer Group
Immunoglobulin Gmg/dL
BECKMAN IMMAGE
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
ELP-B 2011ELP-A 2011ELP-B 2010
SPE-03 4120 3348.4 484.5 110 +1.6 1894 4803 AcceptableImmunoglobulin Amg/dL
BECKMAN IMMAGEELP-B 2011ELP-A 2011ELP-B 2010
x: Result is outside the acceptable limits
SPE-03 <4 8 [28]Immunoglobulin Mmg/dL
BECKMAN IMMAGEELP-A 2011ELP-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239252338/8/20119/19/2011
ELP-B 2011 ElectrophoresisE V A L U A T I O NORIGINAL
P = Based on peer group statistics
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
SPE-04 6.3 6.72 0.23 735 -1.8 6.0 7.4 Acceptable
TestUnit of Measure
Peer Group
Protein, Totalg/dL
BIURET
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
ELP-B 2011ELP-A 2011ELP-B 2010
Test
Methods
Unit Of Measure--
Albumin Electrophor g/dLSEBIA MINICAP
Specimen Your Result S.D. Labs Your GradeS.D.ILimits of Acceptability
Lower UpperEvaluation Statistics
Mean
SPE-04 3.9 [26]P 4.03 0.19 33 -0.7Albumin Electrophor %
SEBIA MINICAP SPE-04 61.8 [26]P 60.68 1.49 30 +0.8Alpha 1 Globulin g/dL
SEBIA MINICAP SPE-04 0.3 [26]P 0.29 0.02 34 +0.5Alpha 1 Globulin %
SEBIA MINICAP SPE-04 4.4 [26]P 4.32 0.25 30 +0.3Alpha 2 Globulin g/dL
SEBIA MINICAP SPE-04 0.6 [26]P 0.59 0.03 34 +0.3Alpha 2 Globulin %
SEBIA MINICAP SPE-04 8.9 [26]P 9.02 0.36 30 -0.3Beta Globulin g/dL
SEBIA MINICAP SPE-04 0.6 [26]P 0.64 0.06 34 -0.7Beta Globulin %
SEBIA MINICAP SPE-04 9.2 [26]P 9.64 0.52 30 -0.8Total Gamma Globulin g/dL
SEBIA MINICAP SPE-04 1.0 [26]P 1.08 0.08 34 -1.0Total Gamma Globulin %
SEBIA MINICAP SPE-04 15.7 [26]P 16.34 0.76 30 -0.8
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 4 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239252338/8/20119/19/2011
ELP-B 2011 ElectrophoresisE V A L U A T I O NORIGINAL
TestMethod Specimen Your Result Intended Response Your Grade
Paraprotein IDSPE-04SEBIA CAPILLARYS [11]
SPE-04 NO ABNORMALITYSPE Pattern Interp NO ABNORMALITY Good
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
SPE-04 1140 1109.6 52.8 106 +0.6 832 1387 Acceptable
TestUnit of Measure
Peer Group
Immunoglobulin Gmg/dL
BECKMAN IMMAGE
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
ELP-B 2011ELP-A 2011ELP-B 2010
SPE-04 223 224.4 10.7 105 -0.1 192 257 AcceptableImmunoglobulin Amg/dL
BECKMAN IMMAGEELP-B 2011ELP-A 2011ELP-B 2010
x: Result is outside the acceptable limits
SPE-04 91 93.2 4.5 106 -0.5 79 107 AcceptableImmunoglobulin Mmg/dL
BECKMAN IMMAGEELP-B 2011ELP-A 2011ELP-B 2010
TestMethod Specimen Your Result Intended Response Your Grade
Bence Jones Protein IDUBJP-03OTHER NO BENCE JONES PROTEIN [26]
Bence Jones Protein IDUBJP-04OTHER NO BENCE JONES PROTEIN [26]
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 5 of 5
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239252338/8/20119/19/2011
ELP-B 2011 ElectrophoresisE V A L U A T I O NORIGINAL
Blood Gas / Electrolytes (BGAS435) - Performance Report
Laboratory Results Summary
A ACC 7.397 - 7.4780.0083 0.1
B ACC 7.071 - 7.1520.0069 0.1
C ACC 7.045 - 7.1260.0113 0.2
D ACC 7.489 - 7.5700.0069 0.1
E ACC 7.717 - 7.7970.0094 0.1
A ACC 33.1 - 43.20.80 2.1
B ACC 70.3 - 82.62.07 2.7
C ACC 61.8 - 72.72.29 3.4
D ACC 25.5 - 35.60.69 2.3
E ACC 12.1 - 22.20.64 3.7
A ACC 81.4 - 98.82.90 3.2
B ACC 151.9 - 186.55.76 3.4
C ACC 28.8 - 44.72.64 7.2
D ACC 198.4 - 245.87.88 3.6
E ACC 176.2 - 222.27.65 3.8
CO1033AI PageLaboratorio Medico Las Americas
CAP LAP Number 7181660
Instrument Nickname: GemSubscription ID 32219 Cycle: 03 - 2011
Results Deadline 2011/Sep/27
Analyte Sample Problem Code
SDICOMPARATIVE GROUP DATA
CV(%)
» pH
ID:IL GEM Premier 3000 7.44
ID:IL GEM Premier 3000 7.12
ID:IL GEM Premier 3000 7.09
ID:IL GEM Premier 3000 7.53
ID:IL GEM Premier 3000 7.75
Analyte Score: 100.00%
» pCO2 mm Hg
ID:IL GEM Premier 3000 37
ID:IL GEM Premier 3000 74
ID:IL GEM Premier 3000 64
ID:IL GEM Premier 3000 30
ID:IL GEM Premier 3000 17
Analyte Score: 100.00%
» pO2 mm Hg
ID:IL GEM Premier 3000 93
ID:IL GEM Premier 3000 174
ID:IL GEM Premier 3000 36
ID:IL GEM Premier 3000 229
ID:IL GEM Premier 3000 207
Analyte Score: 100.00%
Grade: ACC - Acceptable; UNACC - Unacceptable; *ACC or *UNACC: Ungradable result due to either lack of peer group consensus or insufficient number of participants. As required by CLIA/CAP, you must verify the accuracy of these ungradable results.» This result is designated for regulatory purposes.Peer Group(PG) Codes: AR-all results; AU-all results in specific unit; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument modelProblem Codes: 1(Failure to participate); 2(Failure - Excl Requested); 11(Below Linear/Detection Limit); 22(Above Linear/Detection Limit); 33(Analyzer Out of Service); 66(Specimen Not Appropriate); 88(Testing Suspended During Test Event);
DigitalPT Support from AccuTest Member_DigitalPT International EQA [email protected] | tel 604.222.3900 | fax 604.222.3901 | www.digitalpt.comPO Box 999 Westford, MA, 01886, USA
82 7.43790.25
83 7.11191.17
81 7.08510.44
83 7.52930.10
82 7.7570-0.74
80 38.13-1.40
81 76.41-1.16
82 67.24-1.42
80 30.55-0.80
81 17.12-0.19
79 90.101.00
80 169.190.84
80 36.77-0.29
79 222.060.88
79 199.161.02
3 of 3 2011/Oct/04Print Date
Instrument Model: IL GEM Premier 3000
YOUR LAB'S DATAResult Grade Peer Group Code:Description Acceptable Results
Laboratory
Test event
1 / 3
Statistical Count
Contact Name Claudia Velasquez E. Fax 011-574-3400510Email [email protected]
Mean SD
Blood Gas / Electrolytes (BGAS435) - Performance Report
Laboratory Results Summary
A ACC 1.28 - 1.410.020 1.5
B ACC 1.57 - 1.670.016 1.0
C ACC 1.90 - 2.070.027 1.4
D ACC 0.84 - 0.920.011 1.2
E ACC 0.85 - 0.940.013 1.4
A ACC 11.3 - 13.90.21 1.7
B ACC 4.0 - 5.00.16 3.5
C ACC 5.8 - 7.20.17 2.7
D ACC 13.2 - 16.20.31 2.1
E ACC 1.5 - 2.30.15 8.0
A ACC 5.0 - 7.60.21 3.3
B ACC 2.9 - 4.40.09 2.4
C ACC 2.0 - 3.00.08 3.2
D ACC 7.1 - 10.80.21 2.3
E ACC 0.6 - 1.10.08 9.9
CO1033AI PageLaboratorio Medico Las Americas
CAP LAP Number 7181660
Instrument Nickname: GemSubscription ID 32219 Cycle: 03 - 2011
Results Deadline 2011/Sep/27
Analyte Sample Problem Code
SDICOMPARATIVE GROUP DATA
CV(%)
» Calcium - Ionized mmol/L
ID:IL GEM Premier 3000 1.35
ID:IL GEM Premier 3000 1.63
ID:IL GEM Premier 3000 1.96
ID:IL GEM Premier 3000 0.89
ID:IL GEM Premier 3000 0.9
Analyte Score: 100.00%
» Glucose mmol/L
ID:IL GEM Premier 3000 12.5
ID:IL GEM Premier 3000 4.4
ID:IL GEM Premier 3000 6.4
ID:IL GEM Premier 3000 14.2
ID:IL GEM Premier 3000 2.1
Analyte Score: 100.00%
» Lactate mmol/L
ID:IL GEM Premier 3000 6.3
ID:IL GEM Premier 3000 3.6
ID:IL GEM Premier 3000 2.5
ID:IL GEM Premier 3000 8.8
ID:IL GEM Premier 3000 0.9
Analyte Score: 100.00%
Grade: ACC - Acceptable; UNACC - Unacceptable; *ACC or *UNACC: Ungradable result due to either lack of peer group consensus or insufficient number of participants. As required by CLIA/CAP, you must verify the accuracy of these ungradable results.» This result is designated for regulatory purposes.Peer Group(PG) Codes: AR-all results; AU-all results in specific unit; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument modelProblem Codes: 1(Failure to participate); 2(Failure - Excl Requested); 11(Below Linear/Detection Limit); 22(Above Linear/Detection Limit); 33(Analyzer Out of Service); 66(Specimen Not Appropriate); 88(Testing Suspended During Test Event);
DigitalPT Support from AccuTest Member_DigitalPT International EQA [email protected] | tel 604.222.3900 | fax 604.222.3901 | www.digitalpt.comPO Box 999 Westford, MA, 01886, USA
34 1.3440.28
34 1.6200.60
33 1.982-0.81
34 0.8820.69
33 0.8930.53
20 12.61-0.51
20 4.47-0.47
20 6.48-0.49
20 14.68-1.54
19 1.881.48
24 6.32-0.10
24 3.63-0.38
24 2.50-0.05
22 8.99-0.90
23 0.850.57
3 of 3 2011/Oct/04Print Date
Instrument Model: IL GEM Premier 3000
YOUR LAB'S DATAResult Grade Peer Group Code:Description Acceptable Results
Laboratory
Test event
2 / 3
Statistical Count
Mean SD
Blood Gas / Electrolytes (BGAS435) - Performance Report
Laboratory Results Summary
A ACC 3.6 - 4.60.07 1.6
B ACC 6.9 - 8.00.06 0.7
C ACC 4.9 - 6.00.03 0.6
D ACC 2.8 - 3.80.00 0.0
E ACC 1.7 - 2.80.05 2.2
A ACC 130 - 1390.9 0.7
B ACC 105 - 1141.0 0.9
C ACC 143 - 1521.4 0.9
D ACC 118 - 1270.9 0.7
E ACC 156 - 1651.6 1.0
CO1033AI PageLaboratorio Medico Las Americas
CAP LAP Number 7181660
Instrument Nickname: GemSubscription ID 32219 Cycle: 03 - 2011
Results Deadline 2011/Sep/27
Analyte Sample Problem Code
SDICOMPARATIVE GROUP DATA
CV(%)
» Potassium mmol/L
ID:IL GEM Premier 3000 4.1
ID:IL GEM Premier 3000 7.4
ID:IL GEM Premier 3000 5.4
ID:IL GEM Premier 3000 3.3
ID:IL GEM Premier 3000 2.3
Analyte Score: 100.00%
» Sodium mmol/L
ID:IL GEM Premier 3000 134
ID:IL GEM Premier 3000 109
ID:IL GEM Premier 3000 148
ID:IL GEM Premier 3000 122
ID:IL GEM Premier 3000 159
Analyte Score: 100.00%
Grade: ACC - Acceptable; UNACC - Unacceptable; *ACC or *UNACC: Ungradable result due to either lack of peer group consensus or insufficient number of participants. As required by CLIA/CAP, you must verify the accuracy of these ungradable results.» This result is designated for regulatory purposes.Peer Group(PG) Codes: AR-all results; AU-all results in specific unit; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument modelProblem Codes: 1(Failure to participate); 2(Failure - Excl Requested); 11(Below Linear/Detection Limit); 22(Above Linear/Detection Limit); 33(Analyzer Out of Service); 66(Specimen Not Appropriate); 88(Testing Suspended During Test Event);
DigitalPT Support from AccuTest Member_DigitalPT International EQA [email protected] | tel 604.222.3900 | fax 604.222.3901 | www.digitalpt.comPO Box 999 Westford, MA, 01886, USA
30 4.10-0.05
30 7.42-0.36
30 5.41-0.33
31 3.300.00
31 2.280.45
31 134.1-0.11
32 109.5-0.54
32 147.70.23
32 122.7-0.80
30 160.1-0.65
3 of 3 2011/Oct/04Print Date
Instrument Model: IL GEM Premier 3000
YOUR LAB'S DATAResult Grade Peer Group Code:Description Acceptable Results
Laboratory
Test event
3 / 3
Statistical Count
Mean SD
EVALUATIONORIGINAL
M-B 2011 Cerebrospinal Fluid Chemistry
INSTITUTION:
ATTENTION:
CAP NUMBER:
Laboratorio Medico Las AmericasMedellin ANT CO
KIT INFORMATION:10/6/20119/6/2011Original Evaluation:
Kit#7181660-01 1
Kit Mailed:23920836 Kit ID:
Claudia Velasquez MT
Next Mailing Date:4/9/2012
COPIED TO: LAP CAP
IMPORTANT NOTES: Participants Reporting Oligoclonal Bands: Because of spacing limitations on this evaluation report, please note that the result descriptionshave been abbreviated. Please refer to your result form or the PSR for the complete descriptions.
LEGEND: Exception Reason Codes appearing in this evaluation:[20] = No appropriate target/response cannot be graded.[26] = Educational challenge.
Reviewed By Date
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 1 of 3
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
M-04 52 53.3 0.9 29 -1.4 47 60 AcceptableM-05 39 38.6 0.7 29 +0.7 32 45 AcceptableM-06 88 89.2 1.5 29 -0.8 80 99 Acceptable
TestUnit of Measure
Peer Group
Glucose CSFmg/dL
ABBOTT ARCHITECT cHEXOKINASE, COLORIMETR
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
M-B 2011M-A 2011M-B 2010
M-04 21M-05 21M-06 21
M-04 8.1 7.80 0.34 25 +0.9 6.7 8.9 AcceptableM-05 10.7 10.04 0.47 25 +1.4 8.6 11.5 AcceptableM-06 1.9 1.89 0.09 25 +0.1 1.4 2.3 Acceptable
Lactatemmol/L
OTHER MULTI ANALYZEROXIDATION (ELECTRODE)
Method Mean
M-B 2011M-A 2011M-B 2010
M-04 2M-05 2M-06 2
M-04 85.7 104.38 8.50 1643 -2.2 83.5 125.3 AcceptableM-05 110.4 124.35 8.58 1643 -1.6 99.4 149.3 AcceptableM-06 36.5 56.26 10.65 1643 -1.9 34.9 77.6 Acceptable
Protein, Total CSFmg/dL
ABBOTT ARCHITECT cPYROGALLOL RED
Method Mean
M-B 2011M-A 2011M-B 2010
M-04 68.3 66.61 3.27 46 +0.5 53.2 80.0 AcceptableM-05 86.2 82.93 3.89 47 +0.8 66.3 99.6 AcceptableM-06 28.8 28.29 2.35 47 +0.2 22.6 34.0 Acceptable
Albumin (CSF)mg/dL
BECKMAN IMMAGEM-B 2011M-A 2011M-B 2010
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 2 of 3
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239208369/6/201110/6/2011
M-B 2011 Cerebrospinal Fluid ChemistryE V A L U A T I O NORIGINAL
Evaluation and Comparative Method Statistics
Specimen MeanYour
Result S.D.No. ofLabs LowerS.D.I Upper
YourGrade
Limits of Acceptability
M-04 192 220.1 24.9 56 -1.1 145 295 AcceptableM-05 225 256.9 27.2 56 -1.2 175 339 AcceptableM-06 26 32.9 4.0 53 -1.7 20 45 Acceptable
TestUnit of Measure
Peer Group
Lactate DehydrogenaseU/L
ABBOTT/37 CABBOTT ARCHITECT c
Plot of the Relative Distance of Your Results from Target as Percentages of allowed Deviation
Survey -100------------Mean-----------+100
M-B 2011M-A 2011M-B 2010
M-04 14.1 14.93 0.67 67 -1.3 11.9 18.0 AcceptableM-05 17.0 16.93 0.85 65 +0.1 13.5 20.4 AcceptableM-06 4.9 5.05 0.24 65 -0.6 4.0 6.1 Acceptable
IgG (CSF)mg/dL
BECKMAN IMMAGEM-B 2011M-A 2011M-B 2010
M-04 66 3 [20]M-05 67 3 [20]M-06 60 3 [20]
Albumin Electrophor%
HELENA TITAN GEL
M-04 19 3 [26]M-05 17 3 [26]M-06 21 3 [26]
Gamma Globulin%
HELENA TITAN GEL
TestMethod Specimen Your Result Intended Response Your Grade
Oligoclonal BandsOLI-04 OLIGOCLON BANDS PRESENTHELENA TITAN GEL OLIGOCLON BANDS PRESENT Good
OLI-05 MATCH OLIGOCLON BND BOTHMATCH OLIGOCLON BND BOTH Good
OLI-06 OLIGOCLON BANDS ABSENTOLIGOCLON BANDS ABSENT Good
0001
The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.
Page 3 of 3
CAP Number:Institution:
Attention:City / State:
Laboratorio Medico Las AmericasClaudia Velasquez MTMedellin ANT CO
7181660-01 Kit# 1 Kit ID: Kit Mailed:
Original Evaluation:
239208369/6/201110/6/2011
M-B 2011 Cerebrospinal Fluid ChemistryE V A L U A T I O NORIGINAL
